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Abstract 
 
Study Design:  A blinded, prospective diagnostic test study was conducted. 
Objectives:  To assess the inter-tester reliability of clinical examination items for carpal 
tunnel syndrome (CTS), to assess the validity of individual clinical test items and self-
report measures for the diagnosis of CTS and to assess the accuracy of an optimum test 
item cluster for the diagnosis of CTS. 
Study Rational:  Examination of the diagnostic validity of various clinical tests for the 
diagnosis of CTS has shown mixed results and the reliability of many of these tests has 
not been determined.  The majority of the diagnostic validity research for CTS has 
examined tests individually which is in contrast to clinical practice where the results of 
multiple tests are combined as part of the clinical reasoning process in order to formulate 
a differential diagnosis:  the test item cluster, derived through logistic regression, is 
proposed as a means to integrate the validity of multiple tests. 
Methods:   37 subjects (74 “hands”) were recruited from a convenience sample of 
consecutive patients referred to for electrodiagnostic (EDX) testing due to upper 
extremity symptomatic complaints.  Subjects underwent EDX testing followed by 
completion of self-report questionnaires and a standardized clinical examination by 
examiners blinded to EDX results.  Diagnostic validity was determined for both 
“general” and “restricted” CTS classification groupings.  
Results:  Out of 18 clinical test items, 12 had reliability coefficients (i.e. ICC or Kappa) 
of .40 or greater. There were 10 clinical exam and self-report items that were found to 
have likelihood point estimates above 2 or below 0.50 for the general diagnostic 
classification and 6 items had acceptable validity for the restricted classification. The test 
item cluster (TIC) derived for the general classification included “hand numbness” and 
symptom reproduction with the upper limb neurodynamic test 1. The TIC derived for the 
restricted classification included “hand numbness” and the overall score of the symptom 
component of the Bringham Carpal Tunnel Questionnaire.  The 95% confidence intervals 
for most likelihood ratio point estimates were wide. 
Conclusions:  The TICs for both classification groupings did not yield improved 
diagnostic validity beyond that found with the single best test item (“hand numbness”).  
The value of the single best test item “hand numbness” was in a negative response. 
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Further investigation is required to validate the TIC and the single best test item and to 
improve the point estimate precision.   
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1.  INTRODUCTION 
1.1  Purpose of Thesis Study 
§ To assess the inter-tester reliability of clinical examination items for the  
diagnosis of carpal tunnel syndrome. 
§ To assess the validity of individual clinical examination items  
and self-report items for the diagnosis of carpal tunnel syndrome. 
§ To assess the validity of an optimum test item cluster for the diagnosis  
of carpal tunnel syndrome. 
 
1.2  Literature Review 
 
1.2.1  Carpal Tunnel Syndrome  
  
1.2.1.1  CTS Description: 
Carpal tunnel syndrome (CTS) can be a cause of pain and functional impairment 
of the hand due to compression of the median nerve at the wrist.1,2  Usual symptoms 
include numbness, tingling and pain predominantly in the median nerve distribution of 
the hand; however, the symptoms can frequently be present in all fingers of the hand3 or 
proximally in the forearm. The symptoms may or may not be accompanied by objective 
changes in sensation and strength of median-innervated structures in the hand. 4  
 
1.2.1.2  CTS Frequency: 
The reported frequency of CTS is variable and is dependent on the type of criteria 
used to identify the presence of the condition and the population studied.  The prevalence 
has been estimated to 50 - 160 cases per 1000 subjects in the general population 5,6,7 and 
up to 500 cases per 1000 subjects in certain high risk groups.8  Incidence may be as 
anywhere from 2.5 cases per 1000 subjects9 to as high as 150 per 1000 subjects per 
year.10   
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1.2.1.3  CTS Associated Factors: 
 Carpal tunnel syndrome is associated with numerous epidemiological risk factors 
including genetic, medical, social, vocational, avocational and demographic.  However, 
definitive causal factors for CTS have yet to be identified. Women are much more 
susceptible than men to develop CTS; the female to male ratio has been reported to be 
from 3 to 10 : 1. 6,11 The peak age of development for CTS is 45-60 years 6 with an 
estimated 10% of people with CTS younger than 31 years. 6,9 Caucasians are more likely 
than African Americans to develop CTS. 10,12  Increased body mass index (BMI) 
(especially a recent increase), short stature, dominant hand and square shaped wrist are 
other factors associated with CTS.9 A strong familial susceptibility for CTS, related to 
inherited genetic characteristics and medical conditions, may exist. 9 Medical conditions 
that may be related to the development of CTS include history of a colles fracture 
(fracture of distal radius), space occupying lesions in the carpal tunnel (e.g. flexor 
tenosynovitis, ganglions, hemorrhage, edema), diabetes, rheumatoid arthritis, 
osteoarthritis of the carpo-metacarpal joint of the thumb and recent menopause.9,11 
Vocational and avocational activities with prolonged severe force through the wrist, high 
amounts of repetitive movements, prolonged extreme factors and exposure to vibration 
and/or cold may also be associated with the development of CTS. 9,11 Other associated 
risk factors include:  pregnancy, use of a walking aid or wheelchair, smoking and alcohol 
use. 11 
 
1.2.1.4  CTS Treatment: 
 Numerous treatment options exist for the management of CTS symptoms.  Mild 
symptoms of short duration are thought to be self-limiting and will often resolve with 
conservative measures (i.e. splinting, non-steroidal anti-inflammatory drugs (NSAIDs), 
activity modification).  Clinical management of more severe cases may include local 
corticosteroid injection or surgical release of the transverse ligament.   
Clinical trials examining the effectiveness of various management options show 
variable results.  Surgical treatment has been shown to be more effective than splinting in 
moderate to severe cases of CTS. 13 Surgical release of the median nerve, however, can 
have a 15-20% failure rate with variable long term success rates 14  and the potential for 
  3 
complications. 15,16  Corticosteroid injection is demonstrated to give improved symptom 
relief over placebo or NSAIDs in the short term; however, it shows no difference in 
benefit compared to splinting and NSAID’s beyond 8 weeks.17 Conservative measures 
such as splinting, ultrasound, yoga and carpal bone mobilization18 have shown significant 
short term improvement of CTS symptoms; however long term effectiveness has yet to 
be demonstrated and the effectiveness of these measures compared to surgical 
intervention has yet to be determined.  Neurodynamic mobilization is an emerging 
conservative treatment technique that shows some promise for symptomatic management 
of carpal tunnel syndrome.19,20  Given the variable presentation and potentially 
complicated nature of CTS, ultimately a multimodal approach to treatment will likely be 
most effective; this type of approach has yet to be formally examined. 
 
 1.2.1.5  CTS Other Considerations: 
 The incidence of bilateral CTS has been reported to be up to 87% and is often 
associated with symptoms of longer duration.21 There is also evidence of frequent 
subclinical median nerve compression in contralateral limbs of patients with unilateral 
CTS.22  The high frequency of bilateral symptoms suggests that median nerve 
compression distally at the wrist is not likely the sole contributor to CTS symptoms; the 
double crush hypothesis may partially explain this phenomenon.  
The double crush hypothesis states that a proximal source of nerve compression 
or stretch would make the distal nerve more susceptible to compression.23 This clinically 
based hypothesis came from observations of coexistence of cervical discogenic disease 
with CTS.  Recent research using MRI has demonstrated a higher incidence of narrowed 
cervical foraminae in CTS patients and a concordance with affected nerve roots on the 
same side as the CTS, which supports the double crush hypothesis.24  
 
1.2.2  Neurodynamics 
 
 1.2.2.1  Definition: 
 Neurodynamics refers to the mechanics and physiology of the nervous system and 
how they relate to each other.  The nervous system exists in physiological and 
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mechanical continuity.25   For example, mechanical stresses applied to nerves evoke 
physiological responses such as alterations in axonal transport or intraneural blood flow; 
conversely, any physiological disturbance of the nerve, such as with diabetes, predisposes 
it to mechanical disturbances.26   
 
1.2.2.2  Neurodynamics’ relationship to CTS: 
   Restricted longitudinal movement of the median nerve in patients with CTS has 
been documented via medical imaging. 27, 28  Limited adaptation of nerve structures to 
changes in length of the nerve path during upper limb movement could eventually be a 
source of neurological symptoms and lead to secondary alterations in nerve function.29  
Physiological sliding could be impaired when the median nerve is trapped at any point 
along its course.  Impaired longitudinal sliding should be considered among the 
mechanisms contributing to electrophysiological abnormalities in patients with CTS. 29 
 
 1.2.2.3  Upper Limb Neurodynamic Tests (ULNT): 
A neurodynamic test is a sequence of movements designed to assess the 
mechanics and physiology of part of the nervous system by elongating the length of the 
nerve and associated connective tissue and by increasing the pressure in and around the 
peripheral nerve.30 The ULNT was initially conceptualized by Elvey31 as a physical 
examination of the neural tissues of the upper quadrant in the investigation of arm pain 
and regional pain syndromes of the upper quarter.  The ULNT provides a simple, 
effective and repeatable method of clinical examination by moving the neural tissues and 
stimulating them mechanically in order to gain an impression of their mobility and 
sensitivity to mechanical stresses.32  The test may elicit a component of neuromechanical 
tension, increased mechanosensitivity or a disturbance of pain mechanisms.  
Neurodynamic testing with a median nerve bias (ULNT1) has been proposed as a 
potentially valid indicator of pathology along the pathway of the median nerve 30 but the 
clinical accuracy of this test for use in CTS has yet to be determined.  
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1.2.3  Carpal Tunnel Syndrome Diagnosis 
 
1.2.3.1  Electrodiagnostic (EDX) Testing  
The goal of electrodiagnostic testing for CTS is to determine whether median 
nerve function is impaired at the wrist.  EDX studies (nerve conduction studies and 
electromyography) can include an examination of both sensory and motor nerves.  There 
is currently no widely agreed upon consensus regarding which EDX study technique or 
combination of techniques is best for detecting CTS 33; however, median nerve sensory 
conduction measures appear to be preferred (if the nerve is intact). 5    
EDX studies are often considered to be the most accurate and one of the few 
“objective” tests to document the presence of CTS.  Other, less common, diagnostic tests 
include ultrasound and magnetic resonance imaging (MRI). EDX studies are far from a 
perfect “gold standard” for CTS diagnosis as false positives and negatives findings with 
this method of testing have been well documented. 33  False negatives can occur because 
of the intermittent nature of the syndrome or because symptoms emanate from small 
unmyelinated fibres that are invisible to surface electrodes (EDX only detects larger 
myelinated fibers).  Carpal tunnel release surgery can be performed successfully in 
patients with normal EDX findings.  In patients with positive EDX findings who undergo 
surgery, their symptoms usually resolve within days despite EDX abnormalities that 
persist for longer. 1 
 
1.2.3.2  CTS Symptom Presentation 
CTS is, by definition, a clinical syndrome with a characteristic symptom 
presentation. The main symptoms of CTS are paresthesia (numbness and/or tingling) and 
pain of the fingers and hand.  Usually the symptoms are in the median nerve distribution 
(Figure 1), but frequently complaints involve all fingers and/or symptoms proximal to the 
wrist.3  
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Figure 1:  Median Nerve Distribution  
 
The presence of “typical” median nerve distributed symptoms does often not necessarily 
correlate with EDX evidence of median nerve pathology.34  Reliance on symptom 
presentation alone for the diagnosis of CTS is, therefore, not ideal. 
 
1.2.3.3  Recommended Diagnostic Criteria 
The combination of electrodiagnostic study findings and symptom characteristics 
likely provides the most accurate CTS diagnosis according to a consensus group of 
medical researchers with experience conducting epidemiological studies of CTS. 33  This 
group combined the symptom presentation gathered from the use of hand diagrams to 
label “classic/probable”, “possible” and “unlikely” symptom characteristics (see Table 1) 
with EDX study findings. 
 
Table 1: Classification of Symptom Quality and Location (From Rempel, 1998)33 
Symptom Description 
Classic/probable Numbness, tingling, burning or pain in at least 2 of digits 1, 2 or 3.  
Palm pain, wrist pain, or radiation proximal to the wrist is allowed 
Possible Tingling, numbness, burning or pain in at least 1 of digits 1, 2 or 3 
Unlikely No symptoms in digits 1, 2, and 3 
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They were unable to come to a consensus on the likelihood of CTS with a combination of 
“classic/probable” symptom presentation and negative EDX studies (see Table 2).  They 
assigned an “ordinal likelihood of CTS” based on the relative diagnostic strength of the 
symptom presentation combined with the EDX results. The group determined that the 
addition of physical examination findings add little diagnostic value if EDX findings and  
 
Table 2: Estimation likelihood of CTS for Case Definitions of CTS that include EDX       
studies (Adapted from Rempel, 1998)33 
Symptom EDX Ordinal likelihood of 
CTS 
Interpretation** 
Classic/probable Positive +++ i.e. High likelihood 
of CTS 
Possible Positive ++ i.e. High likelihood 
of CTS 
Classic/probable Negative +/-* i.e. Mixed likelihood 
of CTS 
Possible Negative - i.e. Low likelihood of 
CTS 
Unlikely Positive - i.e. Low likelihood of 
CTS 
Unlikely Negative -- i.e. Low likelihood of 
CTS 
* No consensus achieved on whether likelihood should be – or +. 
** Thesis author’s interpretation. 
 
 
symptom characteristics are available; however, in the absence of EDX findings, 
combinations of physical examination findings and symptom characteristics provide the 
greatest diagnostic information. 
 
1.2.4  Physical Examination 
 
 1.2.4.1  Types of Validity 
 Validity is the extent to which a meaningful interpretation can be inferred from a 
measurement. 35  There are several different types of validity including construct, content, 
and criterion validity.  Constructs are artificial frameworks which are not directly 
observable.36  Construct validity is often determined through logical argument rather than 
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experimental study.  Construct validation is the theoretical foundation on which all other 
types of validity depend. 30  Content validity deals with the concept of how well the 
measure reflects or samples the construct.  The criterion validation of a measure is 
determined by comparing it with an accepted standard of measurement.  Diagnostic 
validity can be considered a type of criterion validity. 
 
1.2.4.2  Problems with Determining Diagnostic Validity 
A plethora of research has been undertaken to examine the diagnostic validity of 
various physical examination and clinical tests for CTS; fewer studies have examined the 
reliability of these tests (See Table 3).  The results of these studies are extremely variable 
and, because of the use of different criteria standards and control groups, comparison 
among studies is difficult.  
Studies that use asymptomatic patients as controls rather than patients with other 
upper extremity pathologies create an artificial simplicity in diagnosis that does not 
challenge the diagnostic test nor reflect clinical practice, as the role of the clinical test is 
to distinguish CTS patients from those with other pathologies that might be potentially 
confused with CTS. 37   Sackett 38 reports that inclusion of asymptomatic controls can 
overestimate the true accuracy of a test used in clinical evaluation.   
Comparability among studies is also difficult because of the use of differing “gold 
standards.”  A main limitation in the literature is the lack of an ideal criteria standard 
which complicates all research in CTS.  One study may use the results of EDX testing 
only 39, another may use a combination of EDX findings and symptoms 40, and another 
yet may use success with surgery as evidence of CTS.41  
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Table 3: Validity and Reliability of Physical Examination Procedures for CTS* 
Physical 
Examination Test 
Validity Reliability 
Phalen’s42 Sensitivity 67-88% 
Specificity 32-86% 
Intratester kappa=0.53 
Intertester kappa=0.65 
Tinel’s42 Sensitivity26-73% 
Specificity 55-94% 
Intratester kappa=0.80 
Intertester kappa=0.79 
Carpal 
compression test42 
Sensitivity 87% 
Specificity 90-95% 
n/a 
Semmes-
Weinstein 
pressure 
sensibility42 
Sensitivity26-73% 
Specificity 55-94% 
Intratester ICC**=0.15 
Intertester ICC =0.71 
Sharp/Dull 
sensibility42 
Sensitivity 15-93% 
Specificity 51-85% 
n/a 
Thumb abduction 
strength 
(APB)***40 
Sensitivity 66% 
Specificity 66% 
n/a 
Grip strength  Sensitivity 48% 
Specificity 30-38% 41 
Reliability coefficient=0.88 42 
 
Key pinch 
strength 
 
Sensitivity 33% 
Specificity 52-61% 41 
Intratester Pearson r=0.98 
Intertester Pearson r=0.98 42 
Tip pinch strength  
 
Sensitivity 65% 
Specificity 38-41% 41 
Intratester Pearson r=0.98 
Intertester Pearson r=0.98 40 
Tripod pinch 
strength 
Sensitivity 43% 
Specificity 49% 41 
Intratester Pearson r=0.98 
Intertester Pearson r=0.98 42 
ULNT 1 n/a Intratester ICC=0.98 43 
Flick Sign 1 Sensitivity 93% 
Specificity 96% 
n/a 
Thenar eminence 
wasting42 
Sensitivity 3-19% 
Specificity 93-100% 
n/a 
Square shape 
wrist 40 
Sensitivity 69% 
Specificity 73% 
n/a 
*See Appendix A for description of each clinical test and for operational definitions. 
** ICC = intraclass correlation coefficient 
***APB = abductor pollicis brevis 
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1.2.5  Self-Report Measures 
Self-report measures are emerging as important tools for outcome measurement in 
both clinical environments and with intervention studies such as controlled trials.   
 
1.2.5.1  Disability of Arm Shoulder and Hand Questionnaire 
 The DASH (Disability of Arm Shoulder and Hand questionnaire- Appendix A ) 
is an outcome assessment tool of self-perceived disability.44  The DASH has been 
proposed as a valid tool for CTS 45; however, its diagnostic validity for CTS has not been 
examined. 
 
1.2.5.2  Bringham Carpal Tunnel Questionnaire 
A self-administered questionnaire (Bringham Carpal Tunnel Questionnaire- 
BCTQ- Appendix B) for the assessment of severity of symptoms and functional status in 
patients who have CTS was developed by Levine et al.46  The measurement scales have 
been shown to be highly reproducible, internally consistent and responsive to clinical 
change. 46  The diagnostic validity of this tool for CTS has yet to be extensively 
examined. 
 
1.3  Interpretation of Diagnostic Tests: Determining Validity 
 There are various methods for the interpretation of diagnostic tests:  sensitivity, 
specificity, predictive values, likelihood ratios and diagnostic odds ratios (refer to 
Appendix C for brief descriptors of each and formulae for calculating).  The use of 
sensitivity and specificity is far more common than the other measures; recently, 
however, likelihood ratios are being recommended as more clinically relevant. 47, 48   
 Predictive values appear on the surface to be a useful and simple means of 
interpreting clinical test validity:  “given a test result (positive or negative) what is the 
probability that the result is correct?”.47   Predictive values can, however, be deceptive 
because they are highly dependent on the prevalence of the condition of interest in the 
sample.  Positive predictive values will be lower and negative predictive values will be 
higher in samples with a low prevalence of the condition.  The trends reverse if the 
prevalence is high.49 
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 Prevalence levels do not affect sensitivity and specificity in this manner.38  
Sensitivity and specificity values are useful for interpreting clinical tests.  Sackett et al 38 
advocate the use of the following acronyms to assist with ease of interpretation:  
“SnNout” (if sensitivity (Sn) is high, a negative (N) result is useful in ruling out (out) the 
condition) and “SpPin” (if specificity (Sp) is high, a positive (P) result is useful in ruling 
in (in) the condition). 
 Even though sensitivity and specificity values provide useful information, several 
shortcomings have been identified.47  These values tend to work in the opposite direction 
of clinical decision making: clinicians have knowledge of the test result and want to infer 
the probability that a test result is correct, where as sensitivity and specificity values infer 
the probability of a correct test given the result of the reference standard.  Sensitivity and 
specificity values can only be used independently as estimates of the accuracy of negative 
or positive test results, but this information cannot be combined for interpretation.  The 
performance of a diagnostic test, in the context of predictive values, is dependent on the 
pre-test probability that the condition is present.48  Useful tests should produce large 
shifts in probability (i.e. a large change in pre-test probability to post-test probability) 
once the result of the test is known.50,51  Sensitivity and specificity values cannot be used 
to quantify shifts in probability of the condition.47 
 The use of likelihood ratios (LRs) overcomes the aforementioned shortcomings.  
LRs combine the sensitivity and specificity values into a ratio that can be used to quantify 
shifts in probability once the diagnostic test results are known.52  The positive LR 
indicates the increase in odds favoring the condition when the test is positive.  Tests with 
large positive LRs generally have a high specificity because both values reflect the 
usefulness of a positive test.  The negative LR indicates the decrease in odds favoring the 
condition given a negative test result;  a small negative LR means that a test is useful for 
ruling out a condition when negative (small negative LRs usually correspond to high 
sensitivity values).  Refer to Table 4 for a guide to LR interpretation. 
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Table 4:  Interpretation of LR values47 
Positive LR Negative LR Interpretation 
>10 <0.1 Generate large and often 
conclusive shifts in 
probability 
5-10 0.1-0.2 Generate moderate shifts on 
probability 
2-5 0.2-0.5 Generate small but 
sometimes important shifts 
in probability 
1-2 0.5-1 Alter probability to a small, 
and rarely important, degree 
 
 
 Likelihood ratios can be used as part of the clinical reasoning process to 
determine the post-test probability of a condition given a known or estimated pre-test 
probability (i.e. prevalence).  This can be estimated from a nomogram or calculated via a 
mathematical formula (Appendix C).53 
The diagnostic odds ratio (DOR) is a relatively new, and somewhat controversial, 
means of interpreting diagnostic tests.54 The use of paired indicators, such as positive and 
negative LRs, in comparing the performance of competing tests can be a disadvantage if 
one test does not outperform the other on both indicators.55  The DOR combines the 
positive and negative LR values of a test into one performance indicator which facilitates 
test comparison (see Appendix C for DOR formula).  A disadvantage of the DOR is that, 
as a combined measure, it does not give an indication of the relative value or contribution 
of a positive or negative test result, thus the clinical usefulness is limited. 
 
1.4  Rationale and Significance of Study: 
EDX studies have been touted as the “gold standard” for clinical evidence of 
CTS.  Reliance on EDX alone for diagnosis, even when combined with symptom 
presentation, however, does have several drawbacks.   EDX tests require expensive 
equipment and specialized personnel. They can also be relatively time consuming and 
uncomfortable.  Clinical tests and self-report questionnaires offer the advantage of being 
simple, inexpensive and quick to perform.  Clinical testing and questionnaires can 
potentially be used as a quick screen to determine the likelihood of CTS in the presence 
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of symptoms and contributing historical factors. If a positive likelihood of CTS is 
determined with clinical testing and questionnaires appropriate interventions could be 
undertaken prior to EDX testing. Appropriate interventions could, therefore, be 
potentially initiated earlier; particularly in cases where treatment is delayed until 
confirmation of a diagnosis with EDX testing is obtained. 
 Few studies have examined the reliability of commonly used physical 
examination procedures for CTS diagnosis. The reliability of a test is an important 
precursor to determining its validity.  For example, if a test does not produce consistent 
and repeatable results, then the degree to which a meaningful interpretation can be 
inferred from a test is limited. 
Research to date on clinical test validity for CTS has primarily been done on 
localized tests of provocation at the wrist (e.g. Phalen’s, Tinel’s) or impairment measures 
(e.g. sensation, strength).  The diagnostic validity of the ULNT1 and the BCTQ has been 
examined by a recently published study 56; however the DASH has yet to be examined in 
this regard. 
 The majority of the validity research for CTS has examined clinical tests 
individually.  This is in contrast with clinical practice where the results of multiple tests 
are combined as part of the clinical reasoning process in order to formulate a differential 
diagnosis.  This study proposes to examine the results of multiple tests individually and 
in combination in order to determine if an optimal test cluster can be derived.  The 
development of clinical prediction rules57, or test item clusters (TICs), is a recent trend in 
the literature. Determination of a valid test item cluster (TIC) is a means of combining 
multiple tests in a clinically meaningful way.  A valid TIC would more accurately reflect 
common clinical practice and, hopefully, provide clinicians with a more accurate means 
of diagnosing CTS.  The validation of a TIC will enhance the diagnostic utility of the 
clinical examination, thereby allowing clinicians to better select the need for additional 
diagnostic studies (such as EDX in the case of CTS) and the most appropriate 
interventions. It could also allow researchers to determine criteria for a more 
homogeneous patient sample for clinical trials (and thus a greater likelihood of improved 
outcomes with intervention studies). 58,47  
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2.  METHODOLOGY 
 
2.1  Study Design 
 The study design is a blinded prospective diagnostic test study. A cohort of 
subjects was tested by one or two examiners (for reliability testing).  Both the subjects 
and examiners were blinded to EDX test results.  The examiners were also blinded to the 
subjects’ symptom presentation. 
 
2.2  Study Approval Process 
 Approval for the study was obtained from the University of Saskatchewan 
Behavioural Research Ethics Board on August 19th, 2004 (see Appendix D).  Operational 
approval of the study was subsequently obtained from the Research Services Unit of the 
Saskatoon Health Region on September 23rd, 2004 (see Appendix E). 
 
2.3  Subjects 
 The study subjects were recruited from a convenience sample of patients referred 
to a local Physiatry department for upper extremity EDX testing during two time periods 
(October-December 2004 & April-June 2005).  Subjects with upper quadrant pathologies 
other than CTS were included in order to adequately challenge the diagnostic tests and to 
reflect common clinical practice. 38   
 
 2.3.1  Inclusion Criteria: 
 
o Patients referred to Saskatoon City Hospital Physiatry department for 
EDX testing due to any upper extremity complaints.  Patients may or may 
not have been referred for suspected CTS. 
o Age:  18 + years 
o Informed consent given 
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 2.3.2  Exclusion Criteria: 
 
o Any shoulder, elbow or wrist pathology that limited range of movement 
required for safe completion of ULNT1. 
o Any wrist or hand pathology that would limit safe completion of grip and 
pinch strength maneuvers and Phalen’s test. 
o Language, reading or comprehension barriers that would limit adequate 
completion of the study paperwork 
 
2.4  Measurement Procedures 
 
2.4.1  Operational Definitions / Clinical Tester Preparation 
Operational definitions for all clinical tests (see Appendix F) were developed and 
revised prior to the data collection period in consultation with the second Physical 
Therapist (PT) tester.  The PT testers met on two occasions prior to the first test period to 
review the clinical testing procedures and to ensure consistency in performance and 
interpretation of the tests.  The testers met again prior to the second test period to review 
the performance and interpretation of tests. The testers had 7 and 15 years of clinical 
practice experience respectively and similar post graduate clinical education specializing 
in musculoskeletal assessment and treatment. 
 
2.4.2  Recruitment , Consent  and Blinding 
Patients referred to Saskatoon City Hospital Physiatry Department for EDX testing 
due to upper extremity complaints during the designated study periods were invited to 
participate in the study.  A study recruitment letter (Appendix G) which gave a brief 
overview of the study was sent by the Physiatry Department along with their EDX 
appointment letter.  
The patients attended their scheduled EDX testing appointment.  Following 
performance of the EDX testing and prior to informing the patient of the results of the 
testing, the Physiatrist asked each patient if they were interested in participating in the 
research study.  If the patient expressed an interest, then the patients were directed to talk 
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to the primary PT tester (Primary Investigator) for further information regarding the 
study.  If the subject declined to participate then the results of their EDX tests were then 
given to them by the Physiatrist.   
Interested patients were given a verbal description of the study and questions were 
answered. They were informed that an additional 30-60 minutes will be required in order 
to complete additional paperwork and clinical testing by one or two Physical Therapists. 
They were advised that, should they choose to participate, 10 dollars would be given to 
them to reimburse for their time and for parking. They were also informed that if they 
wished, a summary of the additional information gathered could be forwarded to their 
referring physician (Appendix H). Refer to Figure 2 for a diagramatic explanation of 
subject recruitment, consent and blinding process. 
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Figure 2:  Subject Recruitment, Consent and Blinding Process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient Referral to SCH for EDX 
testing 
Study Recruitment Letter sent with EDX Appointment Letter 
EDX Appointment- Testing done by Physiatrist  
Physiatrist gives brief explanation of study and asks if patient is interested in hearing more 
information on the condition that they will not be provided with their EDX results until after study 
testing is completed 
Patient agrees Patient declines 
EDX results withheld from 
patient 
EDX results given to 
patient by Physiatrist 
Primary Investigator (PT) gives patient 
further information about the study, answers 
any questions and, if the patient agrees to 
participate, verbally screens the patient for 
inclusion/exclusion criteria 
Patient agrees to 
participate 
Patient declines to participate or 
does not meet inclusion criteria 
Consent form completed EDX results given to 
 patient by Physiatrist 
Study paperwork completed 
Physical Screening 
Not Cleared 
EDX results given to 
patient by Physiatrist 
Clinical tests performed by one or 
both PT testers 
EDX results given to 
patient by Physiatrist 
Cleared 
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2.4.3  Data Collection 
Consent forms were completed by patients who agreed to participate (Appendix 
I).  Confidentiality of study subjects was maintained by assigning subject numbers to 
each subject.  Only the subject’s number was present on paperwork used for data 
collection.  The key linking participant name and subject number was kept in a secure 
location onsite at the Physiatry Department and was destroyed upon completion of the 
data collection period. 
Paperwork, including demographic and medical information, vocational/ 
avocational factors, symptom characteristics (i.e. symptom duration and location) 
(Appendix J), BCTQ (Appendix B) and DASH (Appendix A) questionnaires, was 
completed prior to performing the clinical tests. 
Physical screening was done by a Physical Therapist to determine participant’s 
ability to safely complete Phalen’s, ULNT1, grip and pinch maneuvers. 
Clinical measures (Provocation tests:  Phalen’s, Tinel’s, carpal compression test; 
Sensation testing:  Semmes Weinstein pressure sensibility, sharp/dull sensibility; Strength 
testing:  thumb abduction, grip, pinch; Neurodynamic testing:  ULNT1; Other: flick sign, 
square wrist sign, thenar eminence wasting) were performed by a Physical Therapist 
blinded to symptom status and to EDX test results.  (See Appendix F for description and 
operational definitions of each test and Appendix K for clinical test reporting form.) 
A second Physical Therapist tester, blinded to EDX testing results, repeated the 
clinical measures in the same order with a subset of study subjects to determine inter-
rater reliability. The subjects that underwent repeated clinical measures were determined 
in a non-systematic manner and based primarily on the availability of the second PT 
tester. 
EDX testing was done by a Physiatrist or a senior Physiatry Resident supervised 
by the Physiatrist (see Appendix L for overview of procedures and diagnostic criteria for 
CTS).  The Physiatrist reported whether positive or negative EDX findings for CTS were 
found, the severity (mild, moderate or severe) 59and a differential diagnosis (determined 
by the Physiatrist), if available (e.g. ulnar neuropathy, cervical radiculopathy), for each 
tested hand (see Appendix M for EDX reporting form). 
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3.  DATA ANALYSIS 
 
3.1  Descriptive Statistics 
 Descriptive statistics (mean/median, minimum, maximum, standard deviation) for 
continuous variables were calculated. Frequencies were determined for nominal and 
ordinal level variables. Characteristics (age, gender, EDX results) of patients who were 
excluded or who declined to participate were collected and comparisons were done (t-test 
for age and Chi Square for gender and EDX results) to determine if this group differed 
significantly from the study group. 
 
3.2  Reliability 
Inter-tester reliability of dichotomized (i.e. positive or negative) test results was 
determined with a kappa statistic.  Inter-tester reliability of continuous measures was 
assessed via an intraclass correlation coefficient (ICC 2,1)60, with corresponding standard 
error of measurement (SEM) and 95% confidence intervals (95% CIs). Inter-tester 
reliability of categorical measures was calculated by a kappa statistic and 95% CI’s were 
calculated from the standard error (95% CI= ± (1.96)*(SE))61.  The following qualitative 
interpretations for ICC’s and kappa values were used in this study: 
 
ICC Interpretation 43: 
· ‘Poor’= ICC < 0.40 
· ‘Fair’= 0.40 = ICC < 0.70 
· ‘Good’= 0.70  =  ICC < 0.90 
· ‘Excellent’= ICC = 0.90 
 
Kappa Interpretation 47: 
· ‘Poor’= Kappa  < .40 
· ‘Fair to Good’= .40 = Kappa  < .75 
· ‘Excellent’= Kappa = .75 
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3.3  Diagnostic Validity 
Due to the lack of consensus of what constitutes the “gold standard” for CTS 
diagnosis, two CTS classification groups (“general” and “restricted”) were formed for 
separate validity analysis (i.e. diagnostic test accuracy). The “CTS positive” group for the 
“general” classification was formed by EDX positive and probable/  possible symptom 
presentation combined with EDX negative and probable symptom presentation.  The  
“CTS negative” group for the “general classification” was formed by EDX negative and 
negative symptom presentation only.  The “restricted” classification groupings were as 
follows:  “CTS positive” formed by EDX positive and probable or possible symptoms 
presentation only and  ”CTS negative” group formed by EDX negative and negative 
symptom presentation combined with EDX negative and probable symptom presentation 
(see Table 5). 
 
Table 5:  CTS Classification Groups 
 CTS Classification Groups* 
 General Restricted 
Positive CTS 
(Symptom presentation/ 
EDX) 
· Probable/ + or – 
· Possible/ + 
 
· Probable/ + 
· Possible/ + 
Negative 
(Symptom presentation/ 
EDX) 
· Possible/ - 
· Unlikely/ + or - 
· Probable/- 
· Possible/ - 
· Unlikely/ + or - 
* Derived from Rempel 1998 33. 
 
The clinical examination results obtained by the first Physical Therapist examiner 
were used for all computations of diagnostic test accuracy.   
Dichotomized tests results are required to formulate 2x2 contingency tables to 
calculate clinical test accuracy.  The clinical test results of grip, pinch, thumb abduction 
strength, square wrist sign and ULNT were dichotomized into “positive” or “negative” as 
per the Operational Definitions (Appendix F). 
Dichotomization of the self-report measures was done via receiver operator 
characteristic (ROC) curves. ROC curves were used to determine cutoff values for self-
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report measures.62 The cutoff value that maximized both sensitivity and specificity was 
selected.  The symptom (BCTQ-SSS) and function (BCTQ-FN) portions of the CTQ 
were analyzed separately.  An average score was determined for each of the BCTQ-SS 
and BCTQ-FN sections and a score for the DASH was determined via the method 
outlined in Appendix A. The corresponding cutoffs for each of BCTQ-SSS, BCTQ-FN 
and DASH were 2, 1.32 and 15 respectively.   
The results of the questionnaires were only applied to the symptomatic side or 
hand.  If bilateral symptoms were present, the score from the questionnaires was applied 
equally to both hands.  If subjects had only one symptomatic side the asymptomatic hand 
was omitted from the validity analysis.  This resulted in 13 “hands” not included in the 
validity analysis for the questionnaires as there were 13 subjects with a unilateral 
symptom presentation. 
The validity of the individual items of the BCTQ-SSS was also calculated. A 
cutoff that was determined to be clinically relevant was used for analysis.  The responses 
to each item are ordinal (i.e. 1 to 5) with “1” corresponding to absence of the symptom.  
Scores of 2 or greater were considered to be positive (i.e. the presence of the symptom 
was coded as “positive” and its absence was coded as “negative”).  
The ULNT ROM values were dichotomized using two methods.  The first was if 
a greater than 10 degree difference in elbow ROM values was obtained from side to side, 
a positive classification for the more limited side was applied.  The second method used 
was to plot an ROC curve and determine a positive cut-point that optimized both 
sensitivity and specificity (elbow flexion ROM = 37.5 degrees). 
Dichotomization of grip and pinch strength values were determined via the 
method described in Appendix F.  Subjects that had bilateral symptoms designated which 
side was “worse”. The remaining side or hand was coded as “negative”.  Two subjects 
did not report which side was “worse”; however there was less than 12% difference 
between the grip and pinch measures on each side with one of these subjects thus each 
hand was coded as “negative”.  The remaining subject’s grip and pinch data were 
eliminated from the validity analysis.  This method of categorization resulted in 72 hands 
being used for the validity analysis for grip and pinch.  
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Sensitivity, specificity, likelihood ratios and diagnostic odds ratios along with 
95% CI’s 52 were calculated for each clinical test and self-report measures (DASH and 
CTQ) (see Appendix C for formulae).  Separate analysis was performed for both 
“general” and “restricted” CTS classification groups.  The diagnostic accuracy of 
individual test items was considered acceptable if LR+ was 2 or more or if LR- was 0.05 
or less. 47 
 
3.4  Diagnostic Test Item Cluster (TIC) 
Logistic regression was used to identify a test item cluster that may have the 
potential to be a better diagnostic tool than individual clinical test items. The multivariate 
analysis was performed separately for both CTS classification groups (i.e. general and 
restricted). Only those variables with acceptable accuracy (i.e. LR+ = 2 or LR- = .5) as 
determined by the bivariate diagnostic validity analysis were entered into the models.  A 
forward stepwise selection procedure was used to enter variables, with P values of 0.1 for 
entrance to the models and 0.15 for exit from the model.  The method of entry and liberal 
P values were chosen to prevent potentially useful variables from being excluded from 
the models.58  The Hosmer-Lemeshow (HL) summary goodness of fit statistic was used 
to assess the fit of the models to the data and to test the hypothesis that the models fit the 
data (higher P values indicate a better fit).63       
Variables selected by the regression models as diagnostic of CTS were used to 
determine various potentially valid TICs.  The first strategy employed was to use the 
logistic regression strictly as a selection method to identify test items that are likely to be 
most diagnostic for CTS.  The test items identified were combined into various “test 
positive” levels of the TIC.    For example, if items A, B and C were chosen the following 
three “test positive” levels would be considered: 
1. at least one of A, B or C were positive  (TIC 1) 
2. at least 2 of A, B or C were positive  (TIC 2) 
3. all three of A, B and C were positive (TIC 3) 
The second strategy was to use the items selected by the logistic regression and combine 
them into a single “adjusted” TIC.  The sum of the products of the results of each test (X) 
with the corresponding $ coefficients was used to determine the “adjusted” TIC (i.e. $0 + 
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$AXA + $BXB  + $CXC = “adjusted” TIC ).  The “adjusted” TIC, a continuous variable, 
was subsequently dichotomized via plotting an ROC curve to identify the most 
appropriate cut-point for a positive test (i.e. the value that related to the highest sensitivity 
and specificity). 
The diagnostic validity (i.e. sensitivity, specificity, LRs and DORs) was 
calculated for each of the identified TICs as previously described for other dichotomous 
variables. 
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4.  RESULTS 
 
4.1  Descriptive Statistics 
 
A total of 60 patients were eligible to participate in the study during the data 
collection time periods.  Twenty patients declined to participate and three were excluded 
prior to data collection by the Primary Investigator (2 had insufficient wrist range of 
motion due to recent colles fractures and one was unable to read and comprehend the 
paperwork).  The non-participant group characteristics of age, gender and EDX results 
were collected and compared to the study participants. No significant differences were 
found between the groups for age (p=.81), gender (p=.22) or EDX results (p=.75). 
 The descriptive statistics for age and duration of symptoms of the 37 participants 
in the study are listed in Table 6.  The descriptive statistics for other demographic, 
vocational and medical information are listed in Table 7.  Table 8 presents the descriptive 
statistics per hand (n=74) for the CTS classification, EDX results, symptom location 
(according to hand diagram) and symptom side.   
The prevalence of CTS according to the “general” classification was 66.2% 
(49/74) and the prevalence according to the “restricted” classification was 51.4% (38/74).  
 
Table 6:  Descriptive Statistics for Continuous Variables 
Variable Valid N Mean Minimum Maximum SD 
Age (years) 37 50.86 19 85 16.64 
Symptom Duration 
(months) 
34 33.26 3 360 62.36 
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Table 7:  Descriptive Statistics for Categorical Variables 
Variable Frequency Percent 
Gender   
     Female 25 67.6 
     Male 12 32.4 
Marital   
     Married 25 67.6 
     Divorced/Separated/ 
      Widowed 
7 18.9 
     Never Married 5 13.5 
Education   
     < Grade 12 8 21.6 
     Grade 12 14 37.8 
     University / Trade School 15 40.5 
Income   
     <15,000 6 16.2 
     16-29000 6 16.2 
     30-59000 18 48.6 
     60-99000 5 13.5 
     >100,000 1 2.7 
BMI* 64   
     <20 kg/m2 (less than desirable) 1 2.7 
     20-24.9 kg/m2 (desirable) 7 18.9 
     25-29.9 kg/m2 (grade 1 obesity) 13 35.1 
     30-40 kg/m2 (grade  2 obesity) 16 43.2 
Hand Dominance   
     Right 30 81.1 
     Left 6 16.2 
     Both 1 2.7 
Work   
     Full Time 21 56.8 
     Part Time 3 8.1 
     Unemployed 1 2.7 
     House Work 7 18.9 
     Student 2 5.4 
     Retired 3 8.1 
Repetitive Work 23 62.2 
Cold Work 10 27.0 
Vibration Work 8 21.6 
WCB** 2 5.4 
SGI*** 0 0 
Diabetes**** 6 16.2 
Rheumatoid Arthritis**** 3 8.1 
Osteoarthritis**** 3 8.1 
Wrist fracture**** 1 2.7 
Thyroid dysfunction**** 7 18.9 
Smoker**** 6 16.2 
*BMI= Body Mass Index   
**WCB= Worker’s Compensation Board 
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***SGI= Saskatchewan Government Insurance (i.e. post motor vehicle accidents)   
****Subject self-report as per completed “General Paperwork” Appendix I 
 
 
 
Table 8:  EDX Results, Symptom Characteristics and Location 
Variable Frequency Percent 
CTS Classification:   
     Negative 25 33.8 
     Classic/ Negative EDX 11 14.9 
     Possible/Positive EDX 4 5.4 
     Classic/Positive EDX 34 45.9 
EDX:   
     Negative 26 35.1 
     Mild 14 18.9 
     Moderate 26 35.9 
     Severe 8 10.8 
Hand Diagram:   
     Unlikely 23 31.1 
     Possible 5 6.8 
     Probable 46 62.2 
Symptom side   
     Right 6 16.2 
     Left 6 16.2 
     Both 25 67.2 
Worse side   
     Right 15 40.5 
     Left 10 27.0 
 
 
4.2  Reliability 
 Inter-tester reliability was computed using the results from the paired results of 
the first and second PT testers.  There were 24 subjects (48 hands) that were examined by 
both testers.  The 13 subjects not included in the reliability analysis did not differ from 
the other 24 subjects with regard to age (p=.72) and gender (p=.93).   
 The reliability coefficients for the clinical examination items and their associated 
95% CI’s are listed in Table 9.  Eight items had kappa values at least fair or better (kappa 
=0.40).  One item (flick sign) had an “excellent” kappa value (=0.75).  Three items had 
ICC values that were “excellent” (ICC=0.90).  
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Table 9:  Inter-tester Reliability of CTS Clinical Measures 
Clinical Test Kappa ICC 
(2,1) 
SD 
(pooled) 
SEM*** 95 % CI 
**** 
Phalen’s* .58 -- -- -- (.35-.81) 
Tinel’s* .51 -- -- -- (.15-.87) 
Carpal Compression* .67 _ _ _ (.46-.88) 
Sharp/Dull Sensibility* .70 _ _ _ (.50-.90) 
Pressure Sensibility* .64 _ _ _ (.39-.89) 
Grip Strength** _ .99 26.43 kg 3.01 kg (.98-.99) 
Tip to Tip Pinch** _ .76 2.98 kg 1.47 kg (.57-.86) 
Key Pinch** _ .92 4.98 kg 1.40 kg (.86-.96) 
3 Jaw Chuck Pinch** _ .93 4.32 kg 1.13 kg (.88-.96) 
Thumb Abduction Strength* .18 _ _ _ (-.04-.40) 
Flick Sign* .75 -- -- -- (.48-.98) 
Thenar Atrophy* -.08 _ _ _ (-.14-.02) 
Square Wrist Ratio** _ .11 5.75 mm 5.42mm (-.59-.50) 
Square Wrist Ratio* .05 _ _ _ (-.22-.32) 
ULNT 1 ROM** _ .66 22.76 0 13.29 0 (.39-.81) 
ULNT 1 symptom 
provocation* 
.70 _ _ _ (.50-.90) 
ULNT 1 >10deg diff* .05 _ _ _ (-.24-.34) 
ULNT 1 SF provocation* .49 _ _ _ (.24-.74) 
*  Categorical Measures 
** Continuous Measures 
***SEM Calculated as a function of the pooled group SD and 
 the ICC (SEM= SD(pooled) x Ö (1-  ICC)) 43 
**** 95% CIs for ICC’s determined by SPSS V10 softwear.  95% CIs for Kappa values 
calculated from SEM provided by SPSS (± 1.96* SEM). 
 
 
4.3  Diagnostic Validity 
The sensitivity, specificity, likelihood ratios and diagnostic odds ratios for each 
variable and their associated 95% CIs are listed in Tables 10 and 11.  The following 
variables were found to have acceptable diagnostic validity when a “general” CTS 
classification was used:  Phalen’s, carpal compression test, grip strength, thumb 
abduction strength, flick sign, thenar atrophy, ULNT symptoms, BCTQ-FN, item 1 (i.e. 
hand or wrist pain at night) and item 6 (i.e. numbness in hand) of the BCTQ-SSS.  The 
following variables were found to have acceptable diagnostic validity when a “restricted” 
CTS classification was used:  flick sign, thenar atrophy, ULNT symptoms, BCTQ-SSS, 
and item 6 (i.e. hand numbness) and item 11 (i.e. difficulty with grasping and use of 
small objects) of the BCTQ-SSS.   
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Table 10:  Univariate Validity Analysis Summary- Clinical Tests 
Test Item CTS 
Classification 
Sensitivity % 
(95%CI) 
Specificity % 
(95%CI) 
+LR 
(95%CI) 
-LR 
(95%CI) 
Diagnostic 
OR (95%CI) 
Phalen’s General* 53.06  
(39.38,66.30) 
84.00 
(65.35,93.60) 
3.32 
 (1.30,8.46) 
.56  
(.40,.79) 
5.94 
(1.77,19.85) 
 Restricted** 52.63  
(37.26,67.52) 
72.22  
(56.01,84.15) 
1.90  
(1.03,3.48) 
.66 
 (.44,.97) 
2.89  
(1.10, 7.61) 
Tinel’s General* 12.24  
(5.73,24.24) 
92.00  
(75.03,97.78) 
1.53  
(.33,7.04) 
.95  
(.82, 1.12) 
1.61  
(.30, 8.60) 
 Restricted** 13.16  
(5.75,27.33) 
91.67  
(78.17,97.13) 
1.58  
(.41,6.13) 
.95 
 (.81,1.11) 
1.67  
(.37, 7.55) 
CCT General* 55.10 
(41.32,68.15) 
80.00  
(60.87, 91.14) 
2.76  
(1.21, 6.28) 
.56 
 (.39, .81) 
4.91 
 (1.59, 15.20) 
 Restricted** 52.63  
(37.26,67.52) 
66.67  
(50.33, 79.79) 
1.58 
 (.91, 2.74) 
.71 
 (.47,1.07) 
2.22 
 (.87, 5.70) 
Sharp/ Dull  General* 40.82  
(28.22, 54.75) 
72.00  
(52.42, 85.72) 
1.46  
(.71, 2.98) 
.82  
(.59, 1.15) 
1.77 
 (.63, 5.03) 
 Restricted** 36.84  
(23.38, 52.72) 
63.89  
(47.58, 77.52) 
1.02  
(.56, 1.86) 
.99 
(.7, 1.40) 
1.03  
(.40, 2.66) 
Pressure 
Sensation 
General* 14.29 
 (7.1, 26.67) 
88.00  
(70.04, 95.83) 
1.19 
(.34, 4.21) 
.97  
(.81, 1.17) 
1.22  
(.29, 5.20) 
 Restricted** 13.16  
(5.75, 27.33) 
86.11  
(71.34, 93.92) 
.95  
(.30, 3.00) 
1.09 
(.84, 1.21) 
.94  
(.25, 3.56) 
Grip 
Strength 
General* 
 
21.28 
(11.99,34.90) 
92.00 
(75.03,97.78) 
2.66 
(.63,11.21) 
.86 
(.71,1.03) 
3.11 
(.62,15.47) 
 
 
Restricted** 13.51 
 (5.91,27.98) 
80.00 
(64.11,89.96) 
.68 
(.24,1.93) 
1.08  
(.88,1.33) 
.63 
(.18,2.19) 
Tip to tip 
pinch 
General* 19.15 
(10.42,32.54) 
84.00 
(65.35,93.60) 
1.20 
(.41, 3.50) 
.96 
(.77,1.20) 
1.24 
(.34, 4.15) 
 Restricted** 
 
13.51 
 (5.91, 27.90) 
77.14 
(60.98,87.93) 
.59 
(.21,1.64) 
1.12 
(.90,1.40) 
.53 
 (.15,1.80) 
Key Pinch General* 
 
20.00 
(10.90,33.82) 
88.00 
(70.04, 95.83) 
1.67 
(.50,5.60) 
.91 
(.74,1.12) 
1.83 
(.45,7.51) 
 Restricted** 
 
14.29 
(6.26,29.38) 
80.00 
(64.11,89.96) 
.71  
(.25,2.04) 
1.07 
(.87,1.33) 
.67 
 (.19,2.35) 
3 Jaw Chuck 
Pinch 
General* 19.15 
(10.42,32.54) 
84.00 
(65.35,93.60) 
1.20 
(.41,3.50) 
.96 
(.77,1.20) 
1.24 
(.34,4.53) 
 Restricted** 
 
16.22 
(7.65,31.14) 
80.00 
(64.11,89.96) 
.81 
 (.30,2.18) 
1.05 
(.84,1.30) 
.77 
(.23,2.58) 
Thumb 
Abduction  
General* 34.69  
(22.92, 48.69) 
84.00 
(65.35, 93.60) 
2.17  
(.82, 5.76) 
.78  
(.60, 1.02) 
2.79  
(.82, 9.45) 
 Restricted** 36.84 
(23.38, 52.72) 
80.56  
(64.97, 90.25) 
1.90  
(.87, 4.15) 
.78  
(.59, 1.05) 
2.42  
(.84, 6.95) 
Flick sign General* 30.61 
 (19.52, 44.53) 
96.00 
 (80.47, 99.29) 
7.65  
(1.07,54.66) 
.72  
(.59, .89) 
10.59  
(1.31, 85.66) 
 Restricted** 36.84  
(23.38, 52.72) 
94.44  
(81.86, 98.46) 
6.63  
(1.62,27.16) 
.67  
(.52, .86) 
9.92  
(2.06, 47.72) 
Thenar 
Atrophy 
General* 12.24  
(5.73, 24.24) 
98.04 
 (83.70, 99.79) 
6.25  
(.36,107.42) 
.90 
 (.80,1.01) 
6.98  
(.37, 130.24) 
 Restricted** 13.16 
(5.75, 27.33) 
97.22 
(85.83, 99.51) 
4.74 
(.58, 38.61) 
.89  
(.78, 1.02) 
5.30 
 (.59, 47.82) 
Square 
Wrist Sign 
General* 34.69  
(22.92, 48.69) 
76.00 
(56.57, 8.85) 
1.45  
(.65, 3.21) 
.86  
(.64, 1.16) 
1.68  
(.57, 5.00) 
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Table 10:  Univariate Validity Analysis Summary- Clinical Tests (continued) 
Square  
Wrist Sign 
Restricted** 39.47  
(25.60, 55.28) 
77.78  
(61.92, 88.28) 
1.78  
(.86, 3.68) 
.78  
(.57, 1.06) 
2.28  
(.82, 6.33) 
ULNT 
Symptoms 
General* 40.82  
(28.22, 54.75) 
80.00  
(60.87, 91.14) 
2.04  
(.87, 4.79) 
.74  
(.55, 1.00) 
2.76  
(.89, 8.57) 
 Restricted** 44.74  
(30.15, 60.29) 
77.78 
(61.92, 88.28) 
2.01  
(.99, 4.08) 
.71  
(.51, .99) 
2.83  
(1.03, 7.80) 
ULNT ROM 
10 degree diff 
General* 14.29  
(7.1, 26.67) 
84.00  
(65.35, 9.36) 
.89  
(.29, 2.76) 
1.02  
.83, 1.25) 
.88  
(.23, 3.33) 
 Restricted** 7.89  
(2.72, 20.80) 
77.78  
(61.92, 88.28) 
.36  
(.10, 1.24) 
1.18  
(.97, 1.44) 
.30  
(.07, 1.24) 
ULNT ROM 
categorical 
(ROC curve) 
General* 4.08 
(1.13, 13.71) 
92.00 
(75.03, 97.78) 
.51  
(.08, 3.41) 
1.04  
.91, 1.19) 
.49  
(.07, 3.70) 
 Restricted** 5.26 
(1.46, 17.29) 
94.44 
(81.86, 98.40) 
.95  
(.14, 6.37) 
1.00  
(.90, 1.12) 
.94  
(.13, 7.09) 
ULNT SF General* 40.82  
(28.22, 54.75) 
76.00  
(56.57, .89) 
1.70 
(.78, 3.69) 
.78 
(.57, 1.07) 
2.18 
 (.74, 6.43) 
 Restricted** 42.11  
(27.85, 57.81) 
72.22  
(56.01, 84.15) 
1.52  
(.80, 2.89) 
.80 
 (.57, 1.13) 
1.89  
(.72, 5.00) 
BCTQ-SSS  General* 74.47 
 (60.49, 84.75) 
50.00 
(26.80, 73.20) 
1.49 
(.86, 2.58) 
.51 
 (.25, 1.05) 
2.92 
 (.85, 10.04) 
 Restricted ** 81.08 
(65.80, 90.52) 
50.00 
 (31.43,68.57) 
1.62 
(1.06, 2.50) 
.38 
(.17, .82) 
4.29 
(1.36, 13.50) 
BCTQ- FN  General* 76.60 
 (62.78, 86.40) 
64.29 
( 38.78,83.66) 
2.15 
(1.04, 4.41) 
.37 
(.19, .70) 
5.89 
(1.63, 21.29) 
 Restricted** 75.68 
 (59.88, 86.64) 
45.83 
 (27.89,64.93) 
1.40 
 (.93, 2.11) 
.53 
(.26, 1.09) 
2.63 
(.88, 7.90) 
DASH 
 
General* 61.07 
(47.43, 74.21) 
42.86 
( 21.38,67.41) 
1.08 
(.65, 1.79) 
.89 
(.44, 1.81) 
1.21 
(.36, 4.06) 
 Restricted** 62.16 
(46.10,75.94) 
41.67 
(24.47,61.17) 
1.07 
(.70,1.62) 
.91 
(.49,1.70) 
1.17 
(.41,3.35) 
 
* ”CTS positive” group formed by EDX positive and probable or possible symptoms presentation 
combined with EDX negative and probable symptom presentation.  “CTS negative” group formed 
by EDX negative and negative symptom presentation only. 
** ”CTS positive” group formed by EDX positive and probable or possible symptoms 
presentation only.  ”CTS negative” group formed by EDX negative and negative symptom 
presentation combined with EDX negative and probable symptom presentation. 
Clinically significant items are in bold face type. 
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Table 11: Univariate Validity Analysis Summary- BCTQ- SSS 
Test 
Item 
CTS 
Classification 
Sensitivity % 
(95%CI) 
Specificity % 
(95%CI) 
+LR 
(95%CI) 
-LR 
(95%CI) 
Diagnostic 
OR 
(95%CI) 
SSS 1 
 
General* 72.34 
 (58.24, 83.06) 
57.14 
( 32.59, 78.62) 
1.69 
(.90,3.17) 
.48 
(.25, .93) 
3.49 
(1.01, 12.00) 
 Restricted** 72.97  
(57.02, 84.60) 
45.83 
 (27.89, 64.93) 
1.35  
(.89,2.04) 
.59 
(.30, 1.17 
2.29 
(.77, 6.74) 
SSS 2 General* 
 
59.57 
 (45.34, 72.36) 
35.71 
( 16.34, 61.24) 
.93 
(.59,1.46) 
1.13 
(.52, 2.48) 
.82 
(.24, 2.83) 
 Restricted** 
 
62.16 
 (46.10, 75.94) 
41.67 
 (24.47, 61.17) 
1.07 
(.70,1.62) 
.91 
(.49, 1.70) 
1.17 
(.41, 3.35) 
SSS 3  General* 
 
70.21 
 (56.02, 81.35) 
21.43 
( 7.57, 47.59) 
.89 
(.64,1.24) 
1.39 
(.47, 4.16) 
.64  
(.16, 2.66) 
 Restricted** 
 
70.27 
(54.22, 82.51) 
25.00 
 (12.00, 44.90) 
.94  
(.69,1.28) 
1.19 
(.51, 2.79) 
.79 
(.25, 2.50) 
SSS 4 General* 
 
65.96  
(51.67, 77.83) 
35.71 
( 16.34, 61.24) 
1.03 
.66, 1.60) 
.95 
(.43, 2.14) 
1.08 
(.31, 3.75) 
 Restricted** 
 
64.86  
(48.76, 78.17) 
33.33  
(17.97, 53.29) 
.97 
(.67, .1.41) 
1.05 
(.51, 2.16) 
.92 
(.31, 2.73) 
SSS 5 General* 
 
65.96 
 (51.67, 77.83) 
21.43 
( 7.57, 47.59) 
.84 
(.60, 1.18) 
1.60 
(.54, 4.67) 
.53 
(.13, 2.17) 
 Restricted** 
 
70.27 
 (54.22, 82.51) 
52.94  
(36.74, 68.55) 
1.49  
(.99, 2.26) 
.56 
(.31, 1.01) 
2.66 
(1.00, 7.05) 
SSS 6 General* 
 
95.74  
(85.75, 98.83) 
35.71  
( 16.34, 61.24) 
1.49  
(1.00,2.21) 
.12 
(.03, .55) 
12.50 
(2.09, 74.81) 
 Restricted** 
 
97.30  
(86.18, 99.52) 
25.00  
(.12, .45) 
1.30  
(1.02,1.64) 
.11 
(.01, .84) 
12.00 
(1.34,107.36) 
SSS 7 General* 
 
69.23  
(55.73, 80.09) 
57.14 
( 32.59, 78.62) 
1.62 
(.86, 3.04) 
.54 
(.29, .99) 
3.00 
(.89, 10.07) 
 Restricted** 
 
67.57 
 (51.46, 80.37) 
50.00 
 (31.43, 68.57) 
1.35  
(.86, 2.14) 
.65 
(.35, 1.20) 
2.08 
(.73, 5.99) 
SSS 8 General* 
 
89.19  
(80.07, 96.64) 
14.29 
( 4.01, 39.94) 
1.07 
(.85, 1.35) 
.60 
(.12, 2.92) 
1.79 
(.29, 10.99) 
 Restricted** 
 
89.19 
 (75.29, 95.71) 
8.33 
 (2.32, 25.85) 
.97  
(.83, 1.15) 
1.30 
(.26, 6.54 
.75 
(.13, 4.45) 
SSS 9 General* 
 
87.23 
(74.83, 94.02) 
14.29 
( 4.01, 39.94) 
1.02 
(.80, 1.29) 
.89 
(.20, 3.95) 
1.14 
(.20, 6.39) 
 Restricted** 
 
86.49  
(72.02, 94.09) 
12.50  
(4.34, 31.00) 
.99  
(.81, 1.20) 
1.08 
(.28, 4.11) 
.91 
(.20, 4.24) 
SSS 10 General* 
 
72.34  
(58.24, 83.06) 
35.71 
( 16.34, 61.24) 
1.13 
(.73, 1.73) 
.77 
(.33, 1.80) 
1.45 
(.41, 5.16) 
 Restricted** 
 
75.68  
(59.88, 86.64) 
37.50 
 (21.16, 57.29) 
1.21  
(.85, 1.74) 
.65 
(.30, 1.40) 
1.87 
(.61, 5.70) 
SSS 11 General* 
 
72.34 
 (58.24, 83.06) 
42.86 
( 21.38, 67.41) 
1.27 
(.78, 2.06) 
.65 
(.30, 1.38) 
1.96 
(.57, 6.76) 
 Restricted** 
 
78.38  
(62.80, 88.61) 
45.83 
(27.89, 64.93) 
1.45 
(.97, 2.17) 
.47 
(.22, 1.00) 
3.07 
(1.00, 9.41) 
Clinically significant items (i.e. +LR = 2 or –LR = 0.5) are in bold face type. 
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4.4  Diagnostic Test Item Cluster 
Separate analyses for general and specific CTS classification were performed. 
The 10 variables that were found to have acceptable diagnostic accuracy for the “general” 
CTS classification were entered into a regression model as potential predictors for CTS. 
(Refer to Appendix N for SPSS logistic regression results tables). After list-wise deletion, 
a total of 59 “hands” were used in the analysis (45 hands with CTS and 14 control hands).  
The results of the HL test indicated that the model fit the data (p=1.00). The following 
two variables were chosen by the model: BCTQ-SSS item 6 (presence of numbness as a 
symptom) and ULNT1 symptoms (i.e. reproduction of all or part of subject’s symptoms 
with ULNT1 test).  Two “test positive” conditions of the TIC were examined for 
diagnostic validity: TIC 1 (at least 1 of the 2 identified items positive) and TIC 2 (both of 
the identified items positive). An “adjusted” TIC was also determined based on the $ 
coefficients from the logistic regression analysis.   The following formula for the 
“adjusted” TIC model was used:  $0+ $AXA + $BXB.  Where $0=-22.83, $A=23.97, XA = 
BCTQ-SSS item 6, $B= 1.86, and XB=ULNT1 symptoms.  A continuous value for the 
adjusted TIC was derived from this formula so an ROC curve was plotted (using SPSS 
Version 10) to determine the optimal cut-point (-9.92) for a “positive” adjusted TIC. The 
adjusted TIC was subsequently dichotomized based on this cut-point.  The adjusted TIC 
yielded the same results as the single best test item (SSS item 6).   
The 6 variables that were found to have acceptable diagnostic accuracy for the 
“restricted” CTS classification were also entered into a regression model as potential 
predictors of CTS.  After a list-wise deletion of 13 hands (BCTQ items n=61), a total of 
61 hands were used in the analysis (37 hands with CTS and 24 control hands).  The 
results of the HL test indicated that the model fit the data (p=.74).  The following two 
variables were chosen by the model:  BCTQ-SSS item 6 and BCTQ-SSS (average score 
=2 from BCTQ-SSS). Two “test positive” conditions of the TIC were examined for 
diagnostic validity (TIC 1 and TIC 2). The following formula for the “adjusted” TIC 
model was used:  $0+ $AXA + $BXB.  Where $0=-2.23, $A=2.09, XA = CTQ-SS item 6, 
$B= 1.17, and XB=BCTQ-SSS.  A continuous value for the adjusted TIC was derived 
from this formula so an ROC curve was plotted (using SPSS Version 10) to determine the 
optimal cut-point (.45) for a “positive” adjusted TIC. The adjusted TIC was subsequently 
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dichotomized based on this cut-point.  Based on this cut point the adjusted TIC yielded 
the same results as the TIC 2. 
Table 12 provides a summary of the diagnostic validity of TIC 1, TIC 2, and the 
adjusted TIC and the single best test item from the bivariate analysis (BCTQ-SSS item 6) 
for both the general and restricted classification schemes.  
 
 
Table 12: Diagnostic Validity- Multivariate Analysis vs. Single Best Test Item 
Classification Test Item Sensitivity % 
(95%CI) 
Specificity % 
(95%CI) 
+LR 
(95%CI) 
-LR 
(95%CI) 
Diagnostic 
OR (95%CI) 
General TIC 1 95.74 % 
(85.75,98.83) 
7.14% 
(1.27, 31.47) 
1.03 
(.88,1.21) 
.60 
(.06, 6.09) 
1.73 
(.15, 20.64) 
 TIC 2 42.55% 
(29.51,56.72) 
92.86% 
(68.53, 98.73) 
5.96 
(.88, 40.54) 
.62 
(.47, .82) 
9.63 
(1.16, 79.79) 
 Adjusted 
TIC 
95.74% 
(85.75, 98.83) 
35.71% 
(16.34, 61.24) 
1.49 
(1.00, 2.21) 
.12 
(.03, .55) 
12.5 
(2.09, 74.81) 
 Single Best 
Test Item: 
SSS Item 6 
95.74% 
(85.75, 98.83) 
35.71% 
(16.34, 61.24) 
1.49 
(1.00, 2.21) 
.12 
(.03, .55) 
12.5 
(2.09, 74.81) 
Restricted TIC 1 97.30% 
(86.18, 99.52) 
16.67% 
(6.68,35.85) 
1.17 
(.97,1.41) 
.16 
(.02,1.37) 
7.20 
(.75,68.89) 
 TIC2 81.08% 
(65.80,90.52) 
58.83% 
(38.83,75.53) 
1.95 
(1.18,3.20) 
.32 
(.15,.69) 
6.00 
(1.89,19.06) 
 Adjusted 
TIC  
81.08% 
(65.80,90.52) 
58.83% 
(38.83,75.53) 
1.95 
(1.18,3.20) 
.32 
(.15,.69) 
6.00 
(1.89,19.06) 
 Single Best 
Test Item: 
SSS item 6 
97.30 % 
(86.18, 99.52) 
25.00 % 
(.12, .45) 
1.30 
(1.02,1.64) 
.11 
(.01, .84) 
12.00 
(1.34,107.36) 
 
 
4.5  Summary of Results  
 A total of 37 subjects participated in this study resulting in 74 “hands” 
used as the primary unit of analysis.  The categorical clinical examination items that had 
kappa values of .40 (i.e. fair) or greater were:  Phalen’s (.58), Tinel’s (.51), carpal 
compression (.67), sharp/ dull sensibility(.70), pressure sensibility (.64), flick sign (.75), 
ULNT1 symptom provocation (.70), and ULNT1 SF provocation (.49).  The following 
variables were found to have acceptable diagnostic validity when a “general” CTS 
classification was used:  Phalen’s (+LR=3.32), carpal compression test (+LR=2.76), grip 
strength (+LR=2.66), thumb abduction strength (+LR=2.17), flick sign (+LR=7.65), 
thenar atrophy (+LR=6.25), ULNT symptoms (+LR=2.04), BCTQ-FN (+LR=2.15, -
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LR=.37), item 1 (i.e. hand or wrist pain at night) (-LR=.48) and item 6 (i.e. numbness in 
hand) (-LR=.12) of the BCTQ-SSS.  The following variables were found to have 
acceptable diagnostic validity when a “restricted” CTS classification was used:  flick sign 
(+LR=6.63), thenar atrophy (+LR=4.74), ULNT symptoms (+LR=2.01), BCTQ-SSS (-
LR=.38), and item 6 (i.e. hand numbness) (-LR=.11) and item 11 (i.e. difficulty with 
grasping and use of small objects) (-LR=.47) of the BCTQ-SSS.  The TIC derived for the 
general classification grouping was item 6 of the SSS and ULNT 1.  The TIC derived for 
the restricted classification was item 6 of the SSS and overall score of the BCTQ-SSS. 
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5.  DISCUSSION 
 
5.1  Study Design and Potential for Bias 
The optimal design for any research study is the one that most effectively reduces 
susceptibility to bias.  The determination of the validity of diagnostic tests is best 
accomplished through “a prospective, blind comparison of the test and the reference test 
in a consecutive series of patients from a relevant clinical population.”54   Beyond the 
basic design there is potential for bias through other study variables such as the reference 
standard, the diagnostic test and the study population.   
The reference standard used in this study was the combination of EDX testing and 
symptom location (as per the hand diagram Appendix J).  The extent to which this 
reference standard determines the “true” presence of CTS is debatable33, although the use 
of both “general” and “restricted” classification criteria in this study does allow for a 
broader interpretation of the results in the absence of a “perfect” gold standard.   
The reference standard used should also be consistent with the intended purpose 
of the diagnostic test47.  The use of EDX test results combined with symptom location is 
a pathoanatomical reflection of the presence median nerve pathology at the wrist and 
hand (i.e. CTS diagnosis); the intended use of the clinical tests and self-report items in 
this study was to identify the presence of CTS (i.e. diagnosis of CTS).  
Verification bias occurs when not all subjects are assessed by use of the reference 
standard in the same way. 65,66 The EDX testing was primarily done by the same 
Physiatrist using the outlined criteria (Appendix L).  A Physiatry resident who used the 
same diagnostic criteria and who was supervised by the Physiatrist also performed some 
of the testing.  The symptom location was determined via the completed hand diagram 
(Appendix J).  The symptom pattern (i.e. probable, possible or unlikely) was classified by 
the primary investigator after the clinical tests had been performed.  The reference 
standard used (i.e. EDX results and symptom pattern) was consistently applied to all 
subjects, thus verification bias was minimized.  
 The reference standard should be independent of the diagnostic test to avoid 
incorporation bias which is likely to inflate the accuracy of a diagnostic test54.  EDX 
testing is independent from any of the clinical tests and self-report items.  The hand 
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diagram was used to determine symptom pattern; however, it could be construed as 
having some of the same elements as the symptom portion of the BCTQ.  Independence 
of these elements was likely maintained as the classification via the hand diagram was 
done solely on the basis of symptom location and not on the basis of the type (i.e. pain, 
numbness, tingling) and severity of the symptoms which were quantified by the BCTQ.   
Review bias may occur if either the reference standard or the diagnostic test is 
judged by an individual with knowledge of the other result or knowledge of the overall 
clinical presentation of the subject.54,67  If blinding is not maintained, judgment of either 
the reference standard or the clinical tests may be influenced by expectations based on 
knowledge of the test results or other clinical information.  The Physiatrist and resident 
were blinded to the results of the clinical tests and self-report items as these occurred 
after the EDX testing was completed.  They were not necessarily blinded to the overall 
clinical presentation of the subject as a standard history of symptoms was performed 
prior to testing.  Thus, judgment of the EDX results may have been somewhat influenced 
by the expectations arising out of this additional clinical and historical knowledge.  The 
Physical Therapists performing the clinical tests as well as the participants were blinded 
from the EDX results until after completion of the study paperwork (including self-report 
items) and the clinical testing.  Blinding the participants from the EDX results was 
essential to prevent that knowledge from influencing their responses to the self-report 
questionnaires or the clinical tests.  The classification of symptom location was done by 
the primary investigator following completion of the data collection period of the study.  
The hand diagram results were separated from the EDX results prior to data entry and no 
attempts to link EDX results and hand diagram classification was done at that time. 
A diagnostic test study should include subjects who would be likely to undergo 
the test(s) in clinical practice. 54,67  Spectrum (or selection) bias occurs when study 
subjects are not representative of the population on whom the test is typically applied in 
practice.54  Avoidance of spectrum bias can be achieved by utilizing a prospective cohort 
design. 67  The subjects for this study were drawn prospectively from a consecutive group 
of patients from a clinical population.   The descriptive characteristics of the study 
sample (Table 5) appear to reflect previous research examining associated factors for the 
development of CTS (refer to “CTS Associated Factors” p. 2). 
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Individuals who are positive on the reference standard should also reflect a 
continuum of severity from mild to severe, and individuals who have a negative result on 
the reference standard should have conditions commonly confused with the condition of 
interest.68  Positive EDX results were classified for each hand as “mild”, “moderate” or 
“severe” by the Physiatrist (Table 7).  A range of values in all categories was obtained 
with most (35.9%) being classified as “moderate”.  The study Physiatrist identified the 
following differential diagnoses among subjects: osteoarthritis of the first carpo-
metacarpal (thumb) joint, trigger finger, neck/shoulder/soft tissue pain, ulnar neuropathy, 
radial neuropathy, diabetic neuropathy, generalized neuropathy, tennis elbow, and focal 
dystonia. Most of these are conditions that may be commonly confused with CTS. 
 
5.2  The Role of Reliability 
This study attempted to quantify inter-rater reliability among clinical diagnostic 
tests for CTS. Beyond the numerous potential sources of variability between the two 
testers, there may have been variability arising from any instruments used (i.e. pinch and 
grip dynamometers, monofilaments, calipers and goniometer) or among each subject 
from one testing period to the other.  A partially standardized approach was used 
whereby some aspects of potential variability were controlled through the use of pre-
determined operational definitions of the clinical tests, indicating method of application 
and criteria for positivity (Appendix F), and two training sessions for the testers ensured 
similarity in application and interpretation of the clinical tests.  This partially 
standardized approach tends to be more clinically useful than a highly standardized 
approach, such as in a lab environment, and yields better reliability than a non-
standardized approach.69 
 Comparison of the reliability of the clinical tests examined in this study to prior 
research shows some variability.  The inter-tester reliability of Phalen’s and Tinel’s tests 
had previously been reported by Kulhman &  Hennessey42 to have kappa values of .65 
and .79 respectively; confidence intervals were not reported in this cited study. These 
point estimates for reliability differ from this study’s findings (Phalen’s kappa=.58 
Tinel’s kappa= .51); however the 95% confidence intervals (Phalen’s 95%CI= .38-.81, 
and Tinel’s 95% CI= .15-.87) are inclusive of the kappa values previously determined by 
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Kulhman &  Hennessey.42  The reliability of the carpal compression test, sharp/dull 
sensibility, thumb abductor strength test, flick sign, thenar atrophy and square shaped 
wrist had previously not been reported.  Among these the only ones to demonstrate a 
kappa value corresponding to “poor” reliability were thumb abduction strength, thenar 
atrophy and square wrist sign.  The subjective interpretation of thumb abduction strength 
and thenar atrophy was a likely source of variability between testers.  Variability of the 
square wrist sign was potentially influenced by measurement error in either the 
application of the calipers, the degree of pressure applied, or the reading of the caliper 
measurement. Grip strength, key pinch and 3 jaw tripod pinch showed excellent ICC 
values (i.e. >.90).  These values are comparable to previous research (Table 9).  These 
high values are surprising given the many potential sources of variability with these tests 
such as instrument variation, reading errors, variable subject positioning, influences of 
subject pain, and subject effort.  The lower reliability of tip to tip pinch (ICC=.76) is 
likely a reflection on the variability of subject positioning.  Despite instructions provided 
by the testers, subjects in the study often adopted more of a “key pinch” positioning with 
pressure applied though the radial aspect of the index finger instead of through the palmar 
aspect.   
 
  
Figure 3:  Tip to Tip Pinch vs Key Pinch 
 
Among the reliability of the various categorical components of the ULNT (i.e. 
symptom provocation, ROM>10 degrees difference, and SF provocation), symptom 
provocation demonstrated the highest kappa value (k=.70, 95%CI .50-.90). The 
continuous variable of elbow ROM had an ICC of .66 (95%CI .39-.81).  This is in stark 
contrast to Coppieter et al.’s43 study in which a reliability value of ICC=.98 for ULNT 
ROM was obtained.  Equally high levels of inter-tester reliability for both a highly 
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standardized and a partially standardized more clinical approach were reported.  The 
protocol for both involved an electrogoniometer attached to the medial side of the elbow 
to measure ROM.  This study utilized a regular goniometer that was applied to the medial 
aspect of the elbow with fabricated velcro straps.  Maintaining the alignment of the fixed 
and moving arms of the goniometer in order to obtain an accurate reading was difficult, if 
not impossible, for one tester alone to do while still attempting to maintain the upper 
extremity positioning and scapular stabilization required for performance of the ULNT 
(Figure 4).  The use of a regular goniometer in this manner is, however, demonstrative of 
how the test may be carried out in a clinical scenario in the absence of the availability of 
an electrogoniometer. 
 
  
Figure 4:  Goniometer Placement with ULNT1 
 
Coppieters et al. 43 do not clarify how the electrogoniometer was affixed or if an assistant 
was used for the test procedure; these are factors that may potentially influence test 
reliability.  
 Optimization of the reliability of a test may result in improved diagnostic 
validity.70  The reliability of the ROM component of the ULNT demonstrated poor 
reliability and validity (Tables 8 & 9) within this study; however, perhaps performing the 
test in a more reliable manner would result in improved diagnostic validity.69  
Reliability has traditionally been emphasized as a precursor to validity; the 
numerous studies examining test reliability without any assessment of validity attest to 
this approach.  Unfortunately a risk of this is that it may lead to the dismissal of 
potentially useful tests based on the inability to reach an arbitrary threshold of 
reliability.47  Also reliability assessments conducted separately from an examination of 
validity may result in the promotion of highly reliable but diagnostically meaningless 
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tests.47  For these reasons reliability data should be considered a compliment to and not 
only a pre-requisite of an assessment of diagnostic value.   
 
5.3  Validity 
Prior studies examining the diagnostic validity of clinical tests for CTS have, for 
the most part, reported a wide range of point estimates of validity (Table 3), thus 
comparison to the values obtained in this study is somewhat difficult.   
The sensitivity, specificity and LR values in this study are taken from a sample 
and represent an estimate of the true value that could be found in the population52.  The 
confidence interval (CI) indicates the precision of this estimate.  In this case the CI’s for 
all values obtained are quite wide and many include values that are not clinically valid 
(i.e. sensitivity or specificity= 50% or LR=1), thus the usefulness of the tests may be 
questionable.  The width of the CI is often related to the sample size; a priori sample size 
calculation was not carried out in this study. The clinical tests and self-report items that 
were found to be both clinically and statistically valid were (G=general classification, 
R=restricted classification):  Phalen’s (G), carpal compression test (G), Flick sign (G&R), 
BCTQ-Symptom Severity Scale (R), BCTQ-Function (G), SSS 1 (G), and SSS 6 (G & 
R).   
The diagnostic odds ratio (DOR) values for the clinical tests obtained with the 
general CTS classification were generally higher than the restricted classification.  This is 
expected as the general classification is more inclusive of what constitutes a positive test.  
The exceptions to this were Tinel’s (G=1.61, R=1.67), square wrist sign (G=1.68, 
R=2.28), and ULNT symptoms (G=2.76, R=2.83), ULNT ROM (G=.49, R=.94).  Among 
the self-report measures, the overall BCTQ-SSS score (G=2.92, R=4.29), and items 
2(G=.82, R=1.17), 3 (G=.64, R=.79), 5 (G=.53, R=2.66), 10 (G=1.45, R=1.87) and 11 
(G=1.96, R=3.07) of the BCTQ-SSS demonstrated higher DOR’s for the “restricted” than 
the “general” classification groups.  Conversely, the functional component of the BCTQ 
demonstrated higher DOR’s for the “general” than the “restricted” classification groups 
(G=5.89, R=2.63). 
Levine et al46 developed the BCTQ-SS to be a reflection of the severity of 
symptoms in CTS.  The tool was developed through consultation with medical experts 
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and people with CTS in order to develop domains for the symptom severity scale. You et 
al.71 found that the BCTQ-SSS had a “significant relationship” to nerve conduction 
abnormalities and determined there to be a stronger correlation with BCTQ-SSS items 
that were identified to be “primary” symptoms (i.e. numbness, tingling and nocturnal 
symptoms).   
The results from the BCTQ-FN may be reflective of the differences between the 
general and restricted groups. The restricted group was comprised of individuals who 
must have positive EDX findings whereas the general group was comprised of subjects 
with a symptomatic presentation of CTS only.  The greater correlation of the BCTQ-FN 
scores to the general group may indicate a higher overall perceived functional disability 
in this group. 
The DASH has not been previously examined in the context of diagnostic 
validity.  This is an instrument typically used as an outcomes measure for upper 
extremity complaints originating from a variety of different sources.  The results from 
this study do not support its use as a diagnostic predictor of CTS (refer to Table 11, p. 
29). 
Through the transformation of the continuous variables into dichotomous 
variables there is a loss of the discriminative properties of the test.  The dichotomization 
of continuous measures was necessary in order to allow for the calculation of sensitivity, 
specificity and likelihood ratios with a 2x 2 contingency table.  This transformation of 
continuous measures was primarily done by calculating ROC curves and determining a 
cut-point that maximized both sensitivity and specificity.   Had a different cut-point been 
selected then the calculated validity values would have differed.   Riddle and Statford 72 
suggest the use of a “validity index” whereby likelihood ratios are determined at several 
different levels of a continuous measure, thus preserving the discriminative properties of 
the measure. 
On the basis of an estimated prevalence or pre-test probability for CTS of 66.2%   
(“general” classification) or   51.4% (“restricted” classification) in this sample, LR+ 
values exceeding 2 and LR- values less than 0.5 (Table 10) would result in post-test 
probability changes of at least  13.5% for the “general” group and 16.5% for the 
“restricted” group (as per formulae Appendix C).  Tests with the highest +LRs provide 
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the most information in the event of a positive test, and tests with the lowest –LRs 
provide the most information in the event of a negative test.48  Table 13 presents the 
calculated post-test odds for the two tests with the highest +LRs and for the two tests 
with the lowest –LRs for both the general and restricted diagnostic classification groups.  
Clinical tests that result in a large shift in post-test probability are more useful in clinical 
decision making:  they provide clinicians with more information on  the likelihood of a 
particular diagnosis based on either a positive or negative test result.  The absence of 
hand numbness (SSS-6), for example, is, among the items examined in this study, the 
best predictor of ruling out a diagnosis of CTS using both the general and restricted 
classifications as it produces the largest shift in post-test probability based on very low 
negative LR values. 
 
 
Table 13 :  Calculated Post Test Probabilities 
Test LR Value Post-Test Probability Change in probability 
General 
Classification: 
   
     Flick Sign 7.65 93.76% 27.56% 
     Thenar Atrophy 6.25 92.45% 26.25% 
     SSS- 6 0.12 19.0% 47.20% 
     BCTQ-FN 0.37 42.13% 24.07% 
Restricted 
Classification: 
   
     Flick Sign 6.63 89.13% 37.73% 
     Thenar Atrophy 4.74 83.41% 32.01% 
     SSS-6 0.11 10.39% 41.01% 
     BCTQ-SSS 0.38 28.71% 22.69% 
 
 
5.4  Integration and Interpretation of Multiple Clinical Tests 
The interpretation of a single diagnostic test item is simple to do through the use 
of LRs and calculation of post-test probability of a condition given a known or estimated 
pre-test probability 48(Appendix C ).  When there are multiple clinical tests a serial 
multiplication of LRs can be done whereby the post-test probability calculated from the 
first test’s LR becomes the pre-test probability for the second test, and so on. 48, 53  This 
method, however, assumes that the tests are conditionally independent.  If two or more of 
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the tests are not conditionally independent then the estimate diagnostic accuracy may be 
inaccurate. 73 
Holleman & Simel 73 describe four strategies for integration of multiple test 
results:  1) using all items found to be useful by bivariate analysis,  2) using the single 
best LR, 3) using only items identified by a logistic regression analysis, and 4) using only 
items chosen by logistic regression analysis and adjusting the LRs to conform to the 
independence assumption.  The use of the first method can result in decreased diagnostic 
accuracy and potential violation of the independence assumption.  The remaining three 
strategies are proposed by Holleman & Simel as the best methods to integrate multiple 
clinical tests.  Table 12 presents the results from this study using these three strategies. 
The single test item (i.e. SSS item 6= presence of numbness in hands) yielded the best 
diagnostic accuracy of the three methods (DOR=12.5 and 12 for general and restricted 
classification respectively).  
The integration of the results of multiple clinical tests, which includes both 
physical examination and items clinical history (such as symptom presentation), is a vital 
component of an evidence-based clinical reasoning process.  The results from this study 
suggest that the use of every relevant historical item and performing every possible 
physical examination maneuver may not only cause inefficiency, but may also create 
inaccurate assessments (and diagnoses).73  The combination of multiple test results can, 
however, be complicated and fraught with potential bias, particularly from the violation 
of any required assumptions of independence.  The use of logistic regression can be a 
way to overcome this.  An underlying assumption of logistic regression; however, is that 
the independent variables are mutually exclusive or independent74.  It is also proposed 
that a sample size of at least 50 subjects per independent variable might be required for 
accurate hypothesis testing75.   
 Only two items were identified by the logistic regression analysis as significant 
predictors of a CTS diagnosis for each of the general and restricted classification 
schemes. Symptom provocation with the ULNT1 and the presence of numbness as a 
symptom were identified as significant predictors of a “general” CTS classification.  The 
adjusted TIC validity (DOR=12.5) was identical to the validity of the SSS item 6 (i.e. 
single best test item).   The combined validity of both items, TIC 2 (DOR=9.63), was 
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higher than the TIC 1 (DOR=1.73).  Thus the most valid item, related to a CTS general 
classification, is SSS Item 6 on its own; however, symptom provocation with the ULNT 1 
combined with the presence of hand numbness as a symptom (SSS Item 6) appear to have 
promise with respect to CTS diagnosis.  With a restricted CTS classification, SSS item 6 
demonstrated the best validity (DOR=12). The validity of both items identified (i.e. TIC 
2) was identical to the use of the “adjusted” TIC (DOR=6).  Had more variables been 
identified by the logistic regression analysis then an “adjusted” model would have likely 
resulted in a different level of validity than the use of unadjusted variables simply 
identified by the multivariate analysis. 
Wainner and colleagues56  developed a clinical prediction rule for the diagnosis of 
carpal tunnel syndrome that was substantially different from the TICs determined in this 
study.  The results of their study showed that if five items (the BCTQ-SSS score >1.9, a 
wrist ration index of >.67, a patient report of shaking the hand for symptom relief (i.e. 
flick sign), diminished sensation of the thumb pad, and age>45) were present the +LR 
was 18.3 (95%CI: 1.0, 328.3).  Some of the differences may be accounted for in study 
design, and the application and interpretation of clinical tests and self-report items.  The 
reference standard used in Wainner et al’s 56 study was EDX results only in contrast to 
this study where both symptom presentation and EDX results were considered.  Their 
study did not account for bilateral symptom presentation in that only the “more 
symptomatic limb” was considered the involved side. The “more symptomatic limb” as 
interpreted by the subjects may not reflect the relative severity of the condition as 
decreased severity of symptoms, such as paresthesia, tends to occur in more severe cases 
of CTS76.  Their method of sensation testing had not been previously reported thus 
comparison is difficult.  Their interpretation of ULNT positivity included any one of 
three conditions (i.e. symptom reproduction, difference in ROM of > 10 degrees, 
increased or decreased symptoms with neck side flexion away or towards the tested 
limb).  Their study did not find the ULNT1 to be diagnostically valid; however in this 
study ULNT1 symptom reproduction was determined to be diagnostically valid for both 
the general and restricted classification groupings and was an identified item of the 
general TIC.  This study examined the three condition of ULNT1 positivity separately 
and thus this may account for the difference.   This study examined the total average 
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score of the BCTQ-SSS and each individual item whereas Wainner et al56 examined only 
the BCTQ-SSS total score; examination of the individual items of the BCTQ-SSS in this 
study lead to determining the relative predictive value of “hand numbness” for the 
diagnosis of carpal tunnel syndrome.  
The development of a clinical prediction rule that can be readily and accurately 
applied in a variety of clinical settings is a multi-step process 57.  The first step is the 
identification of items that comprise the TIC77.  The next step entails the validation of the 
identified TIC in a different group of patients by a different group of researchers in a 
variety of different clinical settings 77.  This study and Wainner et al’s56 efforts are but the 
first step in this process. 
 
5.5  Study Strengths and Limitations 
The strength of this study lies primarily in the design.  A prospective blinded 
comparison of the clinical tests to a reference standard applied to a consecutive series of 
patients from a relevant clinical population minimizes many of the potential sources of 
bias that can arise from a study of this nature.  This study examines both the reliability 
and the validity of the clinical tests which is essential to determining a complete picture 
of the potential utility of a clinical test.   The inclusion of both traditional (e.g. Phalen’s, 
Tinel’s) and non-traditional clinical tests (e.g. Flick sign, ULNT1) and self-report 
measures (BCTQ and DASH) has not previously been done within the context of CTS 
diagnosis (with the exception of Wainner et al’s study56) The use of two CTS 
classification schemes (i.e. general and restricted) allows for a greater depth of 
interpretation of validity and attempts to overcome the limitations of the use of EDX tests 
on their own as a “gold standard.” 
The greatest limitation of this study is the restricted sample size.  The wide 
confidence intervals for most measures attest to the imprecision of the reliability and 
validity estimates.  An a priori sample size calculation could have been done do 
determine the optimum sample size; however, the number of subjects was primarily 
based on the restricted time line of the study.  The reliability of some clinical tests was 
quite poor.  The inter-rater reliability of ULNT1 ROM measure in particular was low in 
comparison to previous research; this may have ultimately affected the validity of this 
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test.  The ULNT ROM validity was determined on both the basis of an ROC curve cut-
point and the use of a 10 degree difference from side to side.  The latter method is likely 
not an appropriate method of determining positivity in a clinical group that has such a 
high prevalence of bilateral symptom presentation.  The dichotomization of continuous 
variables in this study results in a loss of the discriminative properties of the measure 
which perhaps could have been preserved had a “validity index”72 been used.  The use of 
logistic regression to determine the TICs was likely not the ideal method of analysis in 
this study given the small sample size and the probable violation of the independence 
assumption.   
 
5.6  Future Directions 
A study using a larger sample size is required to increase the precision of the 
diagnostic validity point estimates obtained in the study and to validate the items and 
properties of the TICs produced.  The use of a validated TIC could serve as the basis for 
determination of a homogenous group for clinical trials.  A study examining the 
effectiveness of neuromobilization techniques in patients with CTS demonstrated by the 
combination of numbness and symptom provocation with ULNT 1 may, for example, be 
warranted.  Examination of means to optimize the reliability of some of the clinical tests 
(e.g. ULNT 1 ROM) may result in greater validity and overall diagnostic utility.  Also the 
determination of normative ROM values for the ULNT would lead to improved 
determination of what an “abnormal” test might be, particularly when faced with a 
bilateral symptom presentation.  A trial assessing patient outcomes and cost outlays to 
determine whether patients are benefited by undergoing the clinical tests and self-report 
measures vs. traditional EDX testing may also be warranted.  
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6.  CONCLUSIONS 
 
Most individual items of the clinical examination in this study were found to have 
at least a fair level of reliability.  Those with poor levels of reliability, such as the ULNT 
1 ROM, had many potential sources of variability due to instrument, tester and subject 
influences.  Optimization of reliability may result in improved diagnostic accuracy of 
some tests. 
The clinical test items that had acceptable diagnostic validity with a “general” 
CTS classification were: Phalen’s, carpal compression test, grip strength, thumb 
abduction strength, flick sign, thenar atrophy, and ULNT1 symptom reproduction.  The 
clinical test items that had acceptable diagnostic validity with a “restricted” CTS 
classification were:  flick sign, thenar atrophy, and ULNT symptom reproduction.  For 
most clinical tests the validity values calculated for the general CTS diagnostic 
classification were better than those determined for the restricted classification. 
The findings of this study do not support the use of the DASH as a diagnostic tool 
for CTS. The functional scale of the BCTQ was the only questionnaire that had 
acceptable validity with a general CTS classification.  Only the symptom severity scale of 
the BCTQ had acceptable diagnostic validity with a restricted CTS classification.  The 
individual items of the BCTQ-SSS that had acceptable diagnostic validity were item 1 
(“wrist and hand pain at night”- general classification only), item 6 (“hand numbness”- 
general and restricted classification), and item 11 (“difficulty with grasping and use of 
small objects”- restricted classification only). Hand numbness (SSS item 6) had the best 
validity of any of the individual clinical tests, questionnaires or items from the BCTQ-
SSS for both restricted and general classification schemes. 
The TIC derived through logistic regression for the general classification group 
was SSS item 6 and symptom provocation with ULNT1 and the TIC determined for the 
restricted classification group was SSS item 6 and BCTQ-SSS average score.   The TICs 
for both classification groupings did not yield improved diagnostic validity beyond that 
found with the single best test item (SSS item 6). 
Based on the results of this study the best diagnostic “test” for CTS is not a 
clinical test, per se, but a simple item of clinical history.  Item 6 of the BCTQ-SSS (“hand 
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numbness”) demonstrated the best diagnostic validity when compared to all other 
individual test items and the derived TIC’s for both the general and restricted 
classification schemes.  This item had a low –LR value, thus the diagnostic power of this 
test lies in a negative test result or in the “absence” of hand numbness.   
The process of diagnosis is an essential part of successful clinical management of 
a patient.  The results of individual tests can be used to determine which conditions can 
be ruled in or out, ultimately leading to a decision as to which interventions will provide 
optimum patient outcomes. Clinicians are presented with a plethora of items of history 
and clinical tests are whenever a patient is examined. An evidence-based clinical 
reasoning approach allows a clinician to sift through and priorize between these multiple 
items to determine the likelihood of a diagnosis.  Even though this study showed one item 
(i.e. “hand numbness”) to be diagnostically superior to all other items examined for the 
diagnosis of CTS, the use of only one test item in a clinical scenario is not practical.  
Instead, the findings of this study can be used to assist clinicians determine which items 
of the examination have more or less value for the diagnosis of CTS.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  48 
 
7.  REFERENCES 
 
1 D’Arcy CA, McGee S.  Does this patient have carpal tunnel syndrome?   
Journal of American Medical Association.  2000;283:3110-3117. 
 
2 Phalen GS.  The carpal tunnel syndrome: seventeen years’ experience in diagnosis and 
treatment of six hundred fifty-four hands. J Bone Joint Surg Am.  1966;48:211-228. 
 
3 Stevens JC, Smith BE, Weaver AL et al.  Symptoms of 100 patients with 
electromyographically verified carpal tunnel syndrome.  Muscle and Nerve. 
1999;22:1448-1456. 
 
4 Ashworth NL.  Carpal tunnel syndrome.  E medicine.  2002.  
www.emedicine.com/pmr/topic21.htm. 
 
5 Atroshi I, Gummesson C, Johnsson R, et al.  Prevalence of carpal tunnel syndrome in a 
general population.  JAMA.  1999; 282(2): 153-8. 
 
6 de Krom MC, Kester AD, Knipschild PG, Spaans F.  Risk factors for carpal tunnel 
syndrome.  Epidemiology. 1990 Dec; 132(6):  1102-10. 
 
7 Papanicolaou GD, McCabe SJ, Firrell J.  The prevalence and characteristics of nerve 
compression symptoms on the general population.  J Hand Surg (Am).  2001 May; 26(3):  
460-6. 
 
8 Mondelli M, Giannini F, Giacchi M.  Carpal tunnel syndrome incidence in a general 
population.  Neurology.  2002 Jan; 58(2):  289-94. 
 
 
9 Nordstrom DL, DeStefano F, Vierkant RA, Layde PM.  Incidence of diagnosed carpal 
tunnel syndrome in a general population.  Epidemiology 1998 May; 9(3):  342-5. 
 
10 Garland FC, Garland CF, Doyle EJ Jr et al. Carpal tunnel syndrome and occupation in 
US Navy enlisted personnel.  Arch Environ Health 1996 Sep-Oct; 51(5):  395-407. 
 
11 Falkiner S, Myers S.  When exactly can carpal tunnel syndrome be considered work 
related?  ANZ J Surg.  2002 Mar; 72(3):  204-9. 
 
12 Goga IE.  Carpal tunnel syndrome in black South Africans.  J Hand Surg (Br) 1990 
Feb; 15 (1):  96-99. 
 
13 Verdugo RJ, Salinas RS, Castillo J, Cea JG. Surgical versus non-surgical treatment for 
carpal tunnel syndrome The Cochrane Database of Systematic Reviews 2003, Issue 3. 
Art. No.: CD001552. DOI: 10.1002/14651858.CD001552. 
 
  49 
 
14 Katz JN, Carpal tunnel syndrome: a practical review.  American Family Physician.  
1994; 49(6):  1371-1379. 
 
15 Palmer AK, Toivonen DA.  Complications of endoscopic and open carpal tunnel 
release.  Southern Medical Journal.  1999; 87(3); 416-418. 
 
16Kluge W, Simpson RG, Nicol AC.  Late complications after open carpal tunnel 
decompression.  Journal of Hand Surgery (Am).  1996; 23(4):  697-710. 
17 Marshall S, Tardif G, Ashworth N. Local corticosteroid injection for carpal tunnel 
syndrome (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Chichester, UK: 
John Wiley & Sons, Ltd. 
18 O'Connor D, Marshall S, Massy-Westropp N. Non-surgical treatment (other than 
steroid injection) for carpal tunnel syndrome (Cochrane Review). In: The Cochrane 
Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd. 
19 Tal-Akabi A, Rushton A.  An investigation to compare the effectiveness of carpal bone 
mobilization and neurodynamic mobilization as methods for treatment for carpal tunnel 
syndrome.  Manual Therapy. 2000; 5(4):  214-222. 
 
20 Akalin E et al.  Treatment of carpal tunnel syndrome with nerve and tendon gliding 
exercises.  Am J Phys Med Rehab.  2002; 81(2):  108-113. 
 
21 Padua L, Padua R, Nazzaro M, Tonali P.  Incidence of bilateral symptoms in carpal 
tunnel syndrome.  J Hand Surg (Br).  1998 Oct; 23(5):  603-6. 
 
22 Bodofsky EB, Greenberg WM, Wu KD.  Median nerve compression at the wrist:   is it 
ever unilateral?  Electromyogr Clin Neurophysiol.  2001 Dec; 41(8):  451-6. 
 
23 Upton AR, McComas AJ.  The double crush in nerve entrapment syndromes.  Lancet.  
1973 Aug; 2 (7825):  359-62. 
 
24 Pierre-Jerome C, Bekkelund SI.  Magnetic resonance assessment of the double-crush 
phenomenon in patients with carpal tunnel syndrome:  a bilateral quantitative study.  
Scand J Palst Reconstr Surg Hand Surg.  2003; 37(1):  46-53. 
 
25 Slater H, Butler D, Shacklock MO.  The dynamic central nervous system; examination 
and assessment using tension tests.  In: Boyling J.  Palastanga N (Eds) Grieve’s Modern 
Manual Therapy, 2nd Edn.  Churchill Livingstone:  Edinburgh; pp 587-606. 
 
26 Mackinnon SE, Dallon A, Phillipe JH.  Chronic human nerve compression- a 
histological assessment.  Neuropathology and Applied Neurobiology. 1986; 12. 
 
 
  50 
 
27Greening J, Smart S, Leary R et al.  Reduced movement of median nerve in carpal 
tunnel during wrist flexion in patients with non-specific arm pain.  The Lancet. 1999 
July; 354(9174):  217-8. 
  
28 Nakamichi K, Tachibana S.  Restricted motion of the median nerve in carpal tunnel 
syndrome.  Journal of Hand Surgery (Br).  1995; 20B(4):  460-4. 
 
29 Valls-Sole J, Ramiro A, Nunez M.  Limited longitudinal sliding of the median nerve in 
patients with carpal tunnel syndrome.  Muscle and Nerve.  1995; 18:  761-7. 
 
30 Butler DS.  The Sensitive Nervous System.  Noigroup Publications, Australia, 2000. 
 
31 Elvey RL.  Brachial plexus tension tests and the pathoanatomical origin of arm pain.  
In: Idczak R (ed) Aspects of Manipulative Therapy, Manual Physiotherapists Association 
of Australia, Melbourne.  1979. 
 
32 Shacklock MO. Positive upper limb tension test in a case of surgically proven 
neuropathy: analysis and validity.  Manual Therapy. 1996 June; 1(3):  154-161. 
 
33 Rempel D, Evanoff B, Amadio PC et al.  Consensus criteria for the classification of 
carpal tunnel syndrome in epidemiological studies.  American Journal of Public Health. 
1998 Oct; 88(10):  1447-1451. 
 
34 Ferry S, Silman AJ, Pritchard T, Keenan J, Croft P. The association between different 
patterns of hand symptoms and objective evidence of median nerve compression: a 
community-based survey. Arthritis Rheum. 1998 Apr; 41(4):  720-4. 
 
35 Rosthein JM, Campbell SK, Echternach JL, et al.  Standards for tests and measurement 
in physical therapy practice.  Physical Therapy.  1991; 71:  589-622. 
 
36 Domholdt E.  Physical Therapy Research Principles and Applications.  Toronto:  W.B. 
Saunders Company, 1993:  168-170. 
 
37 MacDermid JC, Kramer JF, McFarlane RM, Roth JH.  Inter-rater agreement and 
accuracy of clinical tests used in diagnosis of carpal tunnel syndrome.  Work A Journal of 
Prevention & Rehabilitation.  1997; 8:  37-44. 
  
38 Sackett DL, Haynes RB, Tugwell P.  Clinical Epidemiology.  A Basic Science for 
Clinical Medicine, Little Brown and Company, Toronto, 1985. 
 
39 Buch-Jaeger N, Foucher, G.  Correlation of clinical signs with nerve conduction tests 
in the diagnosis of carpal tunnel syndrome.  Journal of Hand Surgery (British). 1994;  
19(6):  720-724. 
 
 
  51 
 
40 Kulhman KA, Hennessey WJ.  Sensitivity and specificity of carpal tunnel syndrome 
signs.  American Journal of Physical Medicine and Rehabilitation.  1997; 76(6):  451-
457. 
 
41 Szabo, RM, Slater RR, Farver TB et al.  The value of diagnostic testing in carpal tunnel 
syndrome.  The Journal of Hand Surgery.  1999; 24(A):  704-714. 
 
42 Marx, RG, Bombardier C, Wright JG.  What do we know about the reliability and 
validity of physical examination tests results used to examine the upper extremity?  The 
Journal of Hand Surgery.  1999; 24(A):  185-193. 
 
43 Coppieters M, Stappaerts K, Janssens K.  Reliability of detecting “onset of pain” and 
“submaximal pain” during neural provocation testing of the upper quadrant.  
Physiotherapy Research International.  2002; 7(3):  146-156. 
 
44 Solway S, Beaton DE, McConnell S, Bombardier C.  The DASH outcome measure 
user’s manual, Second edition.  Toronto: Institute for Work & Health, 2002. 
 
45 Beaton DE, Katz JN, Fossel AH et al.  Measuring the whole or the parts? Validity, 
reliability and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome 
measure in different regions of the upper extremity.  2001; 14(2):  128-46. 
 
46 Levine DW, Simmons BP, Koris MJ et al.  A self-administered questionnaire for the 
assessment of severity of symptoms and functional status in carpal tunnel syndrome.  The 
Journal of Bone and Joint Surgery.  1993; 75(11):  1585-92. 
 
47 Fritz JM, Wainner RS.  Examining Diagnostic Tests:  An Evidence Based Perspective.  
Physical Therapy 2001; 81(9):  1546-1564. 
 
48 Sackett DL, Straus SE, Richardson WS et al.  Evidence-Based Medicine- How to 
Practice and Teach EBM.  London:  Churchill Livingstone, 2000:  67-80. 
 
49 Hagen MD.  Test Characteristics:  How good is that test?  Medical Decision 
Making.1995; 22:213-233. 
 
50 Dujardin B.  Van den Ende J.  Van Gompel A.  et al.  Likelihood ratios:  a real 
improvement for clinical decision making?  European Journal of Epidemiology.  1994; 
10: 29-36. 
 
51 Lurie JD, Sox HC.  Principles of medical decision making:  spine update.  Spine.  
1999; 24: 493-498. 
 
 
  52 
 
52 Simel DL, Samsa GP, Matchar DB.  Likelihood ratios with confidence:  sample size 
estimation for diagnostic test results.  Journal of clinical epidemiology.  1991; 44:  763-
770. 
 
53 Davidson M.  The interpretation of diagnostic tests:  a primer for physiotherapists.  
Australian Journal of Physiotherapy.  2002; 48:  227-233. 
 
54 Lijmer JG, Mol BW, Heisterkamp S, et al. Empirical evidence of design-related bias in 
studies of diagnostic tests. JAMA. 1999; 282:1061–1066.  
 
55 Glas AS.  Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM.  The diagnostic odds ratio as  
a single indicator of test performance.  Journal of Clinical Epidemiology.  2003; 56(11):  
1129-35. 
 
56 Wainner RS, Fritz JM, Irrgang JJ, et al.  Development of a clinical prediction rule for 
the diagnosis of carpal tunnel syndrome.  Archives of Physical Medicine and 
Rehabilitation.  2005; 86:  609-618. 
 
57 Cleland J.  Orthopaedic Clinical Examination:  An Evidence-Based Approach for 
Physical Therapists.  New Jersey, Icon Learning Systems, 2005:  16. 
 
58 Wainner RS, Fritz JM, Irrgang JJ et al.  Reliability and Diagnostic Accuracy of the 
Clinical Examination and Patient Self-Report Measures for Cervical Radiculopathy.  
Spine.  2003; 28 (1):  52-62. 
 
59 Stevens CJ.  AAEM Minimograph #36:  The electrodiagnosis of carpal tunnel 
syndrome.  Muscle & Nerve.  1997:  1477-1486. 
 
60 Domholdt E.  Physical Therapy Research Principles and Applications.  Toronto:  W.B. 
Saunders Company, 1993:  287-289. 
 
61 Hazard Munroe B.  Statistical Methods in Health Care Research.  4th ed.:  Philadelphia:  
Lippincott, 2001:  236. 
 
62  Hanley JA, McNeil BJ.  The meaning and use of the area under a received operating 
characteristic (ROC) curve.  Radiology.  1982; 143:  29-28. 
 
63 Hosmer DW, Lemeshow S.  Applied Logistic Regression.  New York:  John Wiley, 
1989:  142-4. 
 
64 Kenney WL, Humphrey RH, Bryant CX eds.  ACSM’s Guidelines for Exercise Testing 
and Prescription, Baltimore:  Williams & Wilkins, 1995:  58-9. 
 
65 Irwig L, Tosteson ANA, Gatsonis C et al.  Guidelines for meta-analyses evaluating 
diagnostic tests.  Annals of Internal Medicine.  1994; 120:  667-676. 
 
  53 
 
 
66 Panzer RJ.  Suchman AM, Griner PF.  Workup bias in prediction research.  Medical 
Decision Making.  1987; 7:  115-119. 
 
67 Reid MC, Lachs MS, Feinstein AR.  Use of methodological standards in diagnostic test 
research:  getting better but still not good.  JAMA.  1995; 274:  645-651. 
 
68 Jaeschke R, Guyatt G, Sackett DL. Users’ guides to the medical literature III: how to 
use an article about a diagnostic test and  are the results of the study valid?  JAMA.  
1994; 271:  389-391. 
 
69 Domholdt E.  Physical Therapy Research Principles and Applications.  Toronto:  W.B. 
Saunders Company, 1993:  162-171. 
 
70 Greenhalgh T.  How to read a paper:  papers that report diagnostic or screening tests.  
BMJ.  1997; 315:  540-543.   
 
71 You H, Simmons Z, Freivalds A et al.  Relationships between clinical symptom 
severity scales and nerve conduction measures in carpal tunnel syndrome.  Muscle & 
Nerve.  1999; 22:  497-501.  
 
72 Riddle DL & Stratford PW.  Interpreting validity indexes for diagnostic tests:  An 
illustration using the Berg Balance Test.  Physical Therapy.  1999;79 (10):  939-948. 
 
73 Holleman DR, Simel DL.  Quantitative assessment from the clinical examination:  how 
should clinicans integrate numerous results?  Journal of General Internal Medicine.  
1997; 12:  165-171. 
 
74 Kleinbaum DG, Klein M.  Logistic Regression A Self-Learning Text 2nd ed.  Springer.  
New York 2002. 
 
75 Grimm LG & Yarnold, PR eds. Reading and Understanding Multivariate Statistics. 
American Psychological Association. Washington D.C. 1995. 
 
76 MacDermid JC, Doherty T.  Clinical Electrodiagnostic Testing of Carpal Tunnel 
Syndrome:  A Narrative Review.  Journal of Orthopaedic & Sports Physical Therapy.  
2004; 34:  565-588. 
 
77 McGinn T Guyatt G, Wyer P et al.  Users’ guide to the medical literature XXII:  how 
to use articles about clinical decision rules.  JAMA. 2000; 284:  79-84. 
 
78  Kendall FP, McCreary EK, Provance PG.  Muscle Testing and Function 4th ed.  
Williams & Wilkins.  Baltimore.  1993. 
 
 
  54 
8.  APPENDICES 
 
 
for a Masters Thesis 
 
 
Reliability and Diagnostic Validity of Clinical Examination and Patient    
Self-Report Measures in Carpal Tunnel Syndrome 
 
Brenna Bath, (MSc Student) 
 
Table of Appendices 
A  Disability of arm shoulder and hand questionnaire (DASH)…………………. 55 
 
B  Bringham Carpal Tunnel Questionnaire (BCTQ) ……………………….. 59 
 
C  Formulae for analysis ………………………………………………………. 64 
 
D U of S Ethics Approval Letter ………………………………………………… 66 
 
E Saskatoon Health Region Approval Letter …………………………………… 67 
 
F  Operational definitions of clinical tests …………………………………… 68  
 
G  Recruitment Letter ……………………………………………………… 75 
 
H Physician Letter………………………………………………………………   76 
 
I  Consent Form ………………………………………………………………. 78 
 
J  General Paperwork ………………………………………………………… 81 
 
K Clinical Test Reporting Form……………………………………………      84  
 
L  Electrodiagnostic procedures ……………………………………………… 85 
 
M EDX Reporting Form………………………………………………………… 86 
 
N SPSS Logistic Regression Results Tables …………………………………….    87 
 
 
 
 
 
 
  55 
APPENDIX A- DISABILITY OF ARM SHOULDER AND HAND 
QUESTIONNAIRE (DASH) 43 
 
Description of Tool: 
 
The DASH is a 30-item self-report condition-specific disability measure.  The 
questionnaire includes 2 physical function items, 6 symptom items and 3 
social/role function items.  Each item of the DASH is scored on a 5 point scale (1 
to 5).   
  
Application/Administration of Tool: 
 
Subjects circle the appropriate response to each question based on their condition 
in the last week.  If the subject did not perform a specific activity in the past 
week, they are asked to make their best estimate of which response would be most 
accurate.  To calculate the overall DASH score, responses to the 30-item DASH 
are summed.  The sum is then transformed so that it falls between 0 and 100 by 
subtracting 30 and dividing by 1.2.  If less than 3 items are blank, the mean score 
of the other items may be substituted for the missing scores.  If four or more 
scores are left blank, a DASH score cannot be calculated. 
 
Interpretation of Tool: 
 
Lower scores reflect less disability and higher scores reflect more disability.  
Preliminary evidence suggests that individuals who are able to do their work 
despite upper extremity pain, tend to score approximately 20-30 on the DASH, in 
contrast to scores in the 50-80 range for those unable to work because of their arm 
problem. 
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DISABILITY OF ARM SHOULDER AND HAND QUESTIONNAIRE (DASH) 
 
INSTRUCTIONS  
§ This questionnaire asks about your symptoms as well as your ability to 
perform certain activities.  
§ Please answer every question, based on your condition in the last week, 
by circling the appropriate number.  
§ If you did not have the opportunity to perform an activity in the past  
week, please make your best estimate on which response would be the 
most accurate.  
§ It doesn’t matter which hand or arm you use to perform the activity; please 
answer based on your ability regardless of how you perform the task.  
 
Please rate your ability to do the following activities in the last week by 
circling the number below the appropriate response.  
 
 NO 
DIFFICULTY 
MILD 
DIFFICULTY 
MODERATE 
DIFFICULTY 
SEVERE 
DIFFICULTY 
UNABLE 
1. Open a tight or new jar. 1 2 3 4 5 
2. Write. 1 2 3 4 5 
3. Turn a key. 1 2 3 4 5 
4. Prepare a meal. 1 2 3 4 5 
5. Push open a heavy door. 1 2 3 4 5 
6. Place an object on a shelf 
above your head. 
1 2 3 4 5 
7. Do heavy household 
chores (e.g., wash walls, 
wash floors) 
1 2 3 4 5 
8. Garden or do yard work. 1 2 3 4 5 
9. Make a bed. 1 2 3 4 5 
10. Carry a shopping bag or 
briefcase. 
1 2 3 4 5 
11. Carry a heavy object 
(over 10 lbs). 
1 2 3 4 5 
12. Change a lightbulb 
overhead. 
1 2 3 4 5 
13. Wash or blow dry your 
hair. 
1 2 3 4 5 
14. Wash your back. 1 2 3 4 5 
15. Put on a pullover sweater. 1 2 3 4 5 
16. Use a knife to cut food. 1 2 3 4 5 
17. Recreational activities 
which require little effort  
(e.g., cardplaying, knitting, 
etc.). 
1 2 3 4 5 
18. Recreational activities in 
which you take some force  
or impact through your arm, 
shoulder or hand  
(e.g., golf, hammering, tennis, 
etc.). 
1 2 3 4 5 
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19. Recreational activities in 
which you move your  
arm freely (e.g., playing 
frisbee, badminton, etc.). 
1 2 3 4 5 
20. Manage transportation 
needs  
(getting from one place to 
another). 
1 2 3 4 5 
21. Sexual activities. 1 2 3 4 5 
 
 NOT AT ALL SLIGHTLY  MODERATELY  QUITE A BIT EXTREMELY 
22. During the past week, to 
what extent has your arm,  
shoulder or hand problem 
interfered with your normal  
social activities with family, 
friends, neighbours or 
groups? 
1 2 3 4 5 
 
 NOT 
LIMITED 
AT ALL 
SLIGHTLY 
LIMITED 
MODERATELY 
LIMITED 
SEVERELY 
LIMITED 
UNABLE 
23. During the past week, 
were you limited in your work  
or other regular daily activities 
as a result of your arm,  
shoulder or hand problem? 
(circle number) 
1 2 3 4 5 
 
Please rate the severity of the following symptoms in the last week.  
(circle number)  
 
 NONE MILD MODERATE SEVERE EXTREME 
24. Arm, shoulder or hand 
pain. 
1 2 3 4 5 
25. Arm, shoulder or hand 
pain when you  
performed any specific 
activity. 
1 2 3 4 5 
26. Tingling (pins and 
needles) in your arm, 
shoulder or hand. 
1 2 3 4 5 
27. Weakness in your arm, 
shoulder or hand. 
1 2 3 4 5 
28. Stiffness in your arm, 
shoulder or hand. 
1 2 3 4 5 
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 NO 
DIFFICULTY 
MILD 
DIFFICULTY 
MODERATE 
DIFFICUTLY 
SEVERE 
DIFFICULTY 
SO MUCH 
DIFFICUTLY 
THAT I 
CAN’T 
SLEEP 
29. During the past week, 
how much difficulty have you 
had sleeping because of the 
pain in your arm, shoulder or 
hand?(circle number) 
1 2 3 4 5 
 
 STRONGLY 
DISAGREE 
DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE STRONGLY 
AGREE 
30. I feel less capable, less 
confident or less useful  
because of my arm, shoulder 
or hand problem.  
(circle number) 
1 2 3 4 5 
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APPENDIX B- BRINGHAM CARPAL TUNNEL QUESTIONNAIRE (BCTQ) 44 
 
Description of Tool: 
 
The BCTQ is a self-administered questionnaire for the assessment of severity of 
symptoms and functional status in patients who have CTS.  The questionnaire 
includes a symptom severity scale with eleven questions covering six “critical” 
domains (pain, parasthesia, numbness, weakness, nocturnal symptoms and over-
all functional status).  It also includes eight items pertaining to functional status 
(i.e. functional status scale).  
 
Application/Administration of Tool: 
  
For both the symptom severity scale and the functional status scale, the subjects 
are asked to base their answers on a typical twenty-four hour period during the 
past two weeks. The symptom severity scale items are rated from 1 point 
(mildest) to 5 points (most severe).  The answers for the functional status scale are 
rated from 1 point (no difficulty with the activity) to 5 points (cannot perform the 
activity at all).   
 
Interpretation of Tool: 
 
The overall symptom severity score is calculated as the mean of the scores for the 
eleven items.  The over-all score for functional status is calculated as the mean of 
all eight items.  Items that are left unanswered are not included in the calculation 
of the overall score.   A lower score represents low reported symptom severity 
and higher functional status.   
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CARPAL TUNNEL QUESTIONNAIRE 
 
Part 1:  Symptom Severity Scale: 
 
 The following questions refer to your symptoms for a typical twenty-four 
hour period during the past two weeks (circle one answer to each question). 
 
§ How severe is the hand or wrist pain that you have a night? 
1  I do not have hand or wrist pain at night 
2  Mild pain 
3  Moderate pain 
4  Severe pain 
5  Very severe pain 
 
§ How often did hand or wrist pain wake you up during a typical night in 
the past two weeks? 
1  Never 
2  Once 
3  Two or three times 
4  Four or five times 
5  More than five times 
 
§ Do you typically have pain in your hand or wrist during the daytime? 
1  I never have pain during the day. 
2  I have mild pain during the day. 
3  I have moderate pain during the day. 
4  I have severe pain during the day. 
5  I have very severe pain during the day. 
 
§ How often do you have hand or wrist pain during the daytime? 
1  I never have pain during the day. 
2  Once or twice a day 
3  Three to five times a day 
4  More than five times a day 
5  The pain is constant 
 
§ How long, on average, does an episode of pain last during the 
daytime? 
1  I never get pain during the day. 
2  Less than 10 minutes 
3  10 to 60 minutes 
4  Greater than 60 minutes 
5  The pain is constant throughout the day. 
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§ Do you have numbness (loss of sensation) in your hand? 
1  No 
2  I have mild numbness 
3  I have moderate numbness 
4  I have severe numbness 
5  I have very severe numbness 
 
§ Do you have weakness in your hand or wrist? 
1  No weakness 
2  I have mild weakness 
3  I have moderate weakness 
4  I have severe weakness 
5  I have very severe weakness 
 
§ Do you have tingling sensations in your hand? 
1  No tingling 
2  I have mild tingling 
3  I have moderate tingling 
4  I have severe tingling 
5  I have very severe tingling 
 
§ How severe is numbness (loss of sensation) or tingling at night? 
1  I have no numbness or tingling at night 
2  Mild 
3  Moderate 
4  Severe 
5  Very severe 
 
§ How often did hand numbness or tingling wake you up during a typical 
night during the past two weeks? 
1  Never 
2  Once 
3  Two or three times 
4  Four or five times 
5  More than five times 
 
§ Do you have difficulty with the grasping and use of small objects such 
as key or pens? 
1  No difficutly 
2  Mild difficulty 
3  Moderate difficulty 
4  Severe difficulty 
5  Very severe difficulty 
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Part 2: Functional Status Scale 
 
 On a typical day during the past two weeks have hand and wrist 
symptoms caused you to have any difficulty doing the activities listed 
below?  Please circle one number that best describes your ability to do 
the activity. 
 
§ Writing 
1  No difficulty 
2  Mild difficulty 
3  Moderate difficulty 
4  Severe difficulty 
5  Cannot do at all due to hand and wrist symptoms 
 
§ Ironing of clothes 
1  No difficulty 
2  Mild difficulty 
3  Moderate difficulty 
4  Severe difficulty 
5  Cannot do at all due to hand and wrist symptoms 
 
§ Holding book while reading 
1  No difficulty 
2  Mild difficulty 
3  Moderate difficulty 
4  Severe difficulty 
5  Cannot do at all due to hand and wrist symptoms 
 
§ Gripping of a telephone handle 
1  No difficulty 
2  Mild difficulty 
3  Moderate difficulty 
4  Severe difficulty 
5  Cannot do at all due to hand and wrist symptoms 
 
§ Opening of jars 
1  No difficulty 
2  Mild difficulty 
3  Moderate difficulty 
4  Severe difficulty 
5  Cannot do at all due to hand and wrist symptoms 
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§ Household chores 
1  No difficulty 
2  Mild difficulty 
3  Moderate difficulty 
4  Severe difficulty 
5  Cannot do at all due to hand and wrist symptoms 
 
§ Carrying of grocery bags 
1  No difficulty 
2  Mild difficulty 
3  Moderate difficulty 
4  Severe difficulty 
5  Cannot do at all due to hand and wrist symptoms 
 
§ Bathing and dressing 
1  No difficulty 
2  Mild difficulty 
3  Moderate difficulty 
4  Severe difficulty 
5  Cannot do at all due to hand and wrist symptoms 
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APPENDIX C–FORMULAE FOR ANALYSIS 
 
Contingency Table Created by comparing the Results of the Diagnostic Test and the 
Reference Standard: 
 
 Reference  
Standard  
Positive  
Reference  
Standard 
Negative 
Diagnostic test positive True positive results (a) False positive results (b) 
Diagnostic test negative 
 
False negative results (c) 
 
True negative results (d) 
 
 
 
§ Sensitivity (%) = a/(a + c) x 100 
o Given that the individual has the condition, the probability that the test 
will be positive 
 
§ Specificity (%) = d/(d + b) x 100 
o Given that the individual does not have the condition, the probability that 
the test will be negative 
 
§ Positive likelihood ratio = sensitivity/(1-specificity) 
o Given a positive test result, the increase in odds favoring the condition 
 
§ Negative likelihood ratio = (1-sensitivity/specificity) 
o Given a negative test result, the decrease in odds favoring the condition 
 
§ Diagnostic Odds Ratio = (a*d)/(b*c) 
o Odds for a positive test results in diseased persons relative to odds of 
positive test results in non-diseased persons 
 
§ Calculation of post-test probability 51: 
o Estimate the pre-test probability (or use known prevalence) 
o Convert to pre-test odds by dividing probability by 1-probability 
o Multiply the pre-test odds by the positive or negative LR value 
o Convert the post-test odds to post-test probability by dividing the odds by 
odds + 1. 
 
§ Use of a likelihood ratio nomogram 46,51: 
o Mark the pre-test probability 
o Mark the LR of the selected tests on the middle line 
o Connect the marks and draw a line which will provide an estimate of post-
test probability. 
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APPENDIX D- U of S ETHICS APPROVAL LETTER 
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APPENDIX E- SASKATOON HEALTH REGION APPROVAL LETTER 
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APPENDIX F- OPERATIONAL DEFINITIONS OF CLINICAL TESTS 
 
Provocation Tests: 
 
 Phalen sign 1: 
§ Test Description: 
o Subject’s wrists are passively flexed to 90 degrees for 60 seconds 
 
§ Definition of Abnormal Finding: 
o Parasthesia (i.e. “pins and needles” sensation) in the distribution of 
the median nerve 
 
§ Level of Measurement for Analysis: 
o Nominal (positive or negative) 
 
Tinel sign 1: 
§ Test Description: 
o Clinician taps on distal palmar wrist crease over the median nerve 
 
§ Definition of Abnormal Finding: 
o Parasthesia in the distribution of the median nerve 
 
§ Level of Measurement for Analysis: 
o Nominal (positive or negative) 
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Carpal Compression Test 1: 
§ Test Description: 
o Examiner presses with his/her thumb on the palmar aspect of the 
subject’s wrist at the level of the carpal tunnel for 60 seconds 
 
§ Definition of Abnormal Finding: 
o Parasthesia in the distribution of the median nerve 
 
§ Level of Measurement for Analysis: 
o Nominal (positive or negative) 
 
 
Sensation Examination: 
 
Hypoalgesia (Sharp/dull sensibility) 1: 
§ Test Description: 
o Examiner uses the sharp tip of an open paper clip (discarded after 
use to prevent infection) to apply a pressure to the subject’s palmar 
aspect of the index finger and to the ipsilateral palmar aspect of the 
little finger.  The subject is asked if they perceive the stimulus 
applied to the index finger to be less than that applied to little 
finger. 
 
§ Definition of Abnormal Finding: 
o Diminished ability to perceive painful stimuli applied to the index 
finger compared to the ipsilateral little finger. 
 
§ Level of Measurement for Analysis: 
o Nominal (positive or negative) 
 
Monofilament Testing (pressure sensibility)1: 
§ Test Description: 
o Semmes-Weinstein monofilaments are applied to the pulp of the 
index finger.  The subject is asked to close his/her eyes and report 
when a pressure sensation is felt. 
 
§ Definition of Abnormal Finding: 
o The subject’s threshold of pressure sensation is greater than the 
2.83 monofilament (i.e. 3.60 or above). 
 
§ Level of Measurement for Analysis: 
o Nominal (positive or negative) 
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Strength Examination: 
 
Grip Strength 39: 
§ Test Description: 
o A Jamar dynamometer was used to measure grip strength.  The 
subject was instructed to grip the device and squeeze as hard as 
they feel comfortable with.  Grip strength was measured at setting 
III on the dynamometer and repeated three times each side.  A 
mean value for each side was used for analysis. 
 
 
§ Definition of Abnormal Finding: 
o Diminished strength more than 12 % less on the affected side than 
the contralateral side. 41   In the case of bilateral CTS, the 
“affected” side will be the side designated to be “worse” or more 
symptomatic by the subject. 
 
§ Level of Measurement for Analysis: 
o Nominal (normal or diminished) 
 
 
Pinch Strength 39: 
§ Test Description: 
o A Jamar pinch dynamometer  was used to measure pinch strength 
of three pinch types (key, tripod and tip to tip pinch).  The subjects 
were instructed to pinch the device and squeeze as hard as they feel 
comfortable with.  Each test was performed three times on each 
side. 
 
 
Tip to tip pinch   Key Pinch 
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Three jaw chuck pinch 
 
§ Definition of Abnormal Finding: 
o Diminished strength more than 12 % less on the affected side than 
the contralateral side39.  In the case of bilateral CTS, the “affected” 
side was the side designated to be “worse” or more symptomatic 
by the subject. A mean value for each side was used for analysis. 
 
§ Level of Measurement for Analysis: 
o Nominal (normal or diminished) 
 
Thumb Abduction Stength 1: 
§ Test Description: 
o The examiner resists thumb abduction (ie. movement of the thumb 
at right angles to the palm). 
 
§ Definition of Abnormal Finding: 
o Strength graded according to manual muscle testing guidelines 78. 
§ Grade 5:  Muscle can hold the test position against strong 
pressure. 
 
§ Grade 4:  Muscle can hold test position against moderate 
pressure. 
 
§ Grade 3:  Muscle can hold test position against gravity, but 
cannot hold if even slightest pressure applied. 
 
§ Grade 2:  Muscle able to move segment through a full 
range in a movement horizontal with respect to gravity or 
partial range of movement in a position against gravity. 
 
§ Grade 1:  Trace evidence of muscle contraction. 
 
§ Grade 0:  No evidence of any muscle contraction. 
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§ Level of Measurement for Analysis: 
o Nominal (normal: 5 or diminished: grade 4 or lower) 
 
Other Tests: 
 
Flick Sign 1: 
§ Test Description: 
o The examiner asks the subject “What do you do with your hand(s) 
when the symptoms are at their worst?”  
§ Definition of Abnormal Finding: 
o The subject demonstrates a flicking movement of the wrist and 
hand similar to that used in shaking down a thermometer. 
 
§ Level of Measurement for Analysis: 
o Nominal (present or absent) 
 
Thenar Atrophy 1: 
§ Test Description: 
o The examiner visually inspects the thenar eminence from the side. 
 
 
 
§ Definition of Abnormal Finding: 
o A concavity of the thenar muscles when observed from the side. 
 
§ Level of Measurement for Analysis: 
o Nominal (present or absent) 
 
Square wrist sign 1: 
§ Test Description: 
o The examiner measures the anterioposterior and mediolateral 
dimensions of the subject’s wrist with calipers at the distal wrist 
crease. 
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§ Definition of Abnormal Finding: 
o The A/P dimension of the wrist divided by the M/L dimension 
equals a ratio of greater than 0.70. 
 
§ Level of Measurement for Analysis: 
o Nominal (positive or negative) 
 
Upper Limb Neurodynamic Test 1 (ULNT  1)30,41: 
§ Test Description: 
o The subject starting position is in supine with both legs extended 
and the cervical spine in a neutral position.  Any deviations from 
the starting position (i.e. use of a pillow or knees flexed were 
recorded and repeated be the second examiner).  The shoulder 
girdle is controlled in a neutral position before the shoulder is 
abducted to 110 degrees.  Consequently, the wrist is extended and 
the forearm supinated before the shoulder is laterally rotated and 
the elbow extended.  The range of elbow extension is measured via 
a goniometer strapped to the subject’s medial arm with the fulcrum 
over the elbow joint.  The test is terminated at the point of elbow 
extension where the patient reports verbally that they are 
experiencing “submaximal pain”(i.e. “a substantial discomfort, 
which corresponds with the greatest level of pain which the subject 
is prepared to tolerate, knowing that the test will be performed 
repeatedly”).  The test is repeated with the neck side flexed away 
(i.e. contralateral) and towards (i.e. ipsilateral) the test arm. 
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§ Definition of Abnormal Finding: 
o Any one of the following criteria was classified as an “abnormal” 
or positive finding: 
§ Reproduction of all or part of participant’s symptoms. 
§ Greater than 10 degree difference in elbow extension 
measured with goniometer 
§ Contralateral neck side flexion increased or ipsilateral neck 
side flexion decreased client’s symptoms.  
 
§ Level of Measurement for Analysis: 
o Nominal (positive or negative) 
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APPENDIX G- RECRUITMENT LETTER 
 
 
Dear Sir/Madame: 
 
 
We would like you to consider volunteering for a research study 
entitled:  “Reliability and diagnostic accuracy of clinical examination 
and patient self report measures in carpal tunnel syndrome”.  The 
purpose of the study is to assess the usefulness of physical tests and 
questionnaires for the diagnosis of carpal tunnel syndrome. 
 
 
You may qualify for the study if you: 
- Have arm or hand symptoms (may or may not be carpal 
tunnel syndrome). 
- Are 18 years or older. 
- Are able to read and understand English. 
 
 
What is involved? 
- Completing paperwork (approximately 15-30 minutes) 
- Undergoing physical tests by one or two Physical Therapists 
(30-60minutes) 
- The paperwork and testing will take place on the same day 
immediately AFTER your scheduled time for 
electrodiagnostic testing at Saskatoon City Hospital. 
- A parking reimbursement of $10 will be given to you for 
participating in the study. 
 
 
If you are interested in participating in this study, please notify the 
Rehabilitation Department receptionist when you attend your 
appointment. 
 
 
If you have any further questions, please contact: 
Brenna Bath at 306 343 9984 
or email:  bathb@shaw.ca 
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APPENDIX H- PHYSICIAN LETTER 
Date:  
 
 
Re.: 
 
 
Dear Dr.    ,   
 
Your patient consented to participate in a research study entitled: “Reliability and 
Diagnostic Accuracy of Clinical Examination  and Self-Report Measures in Carpal 
Tunnel Syndrome”.  As part of this study your patient completed questionnaires 
and underwent additional clinical examination procedures completed by a 
Physical Therapist.   
 
Your patient agreed to have the results of this additional testing sent to you for 
your information.   
 
The results were as follows: 
 
Self Report Questionnaires: 
§ Disability of Arm Shoulder and Hand Questionnaire:     
Lower scores reflect less perceived disability and higher scores reflect more 
perceived disability. 
 
 
§ Carpal Tunnel Questionnaire: 
A lower score represents low reported symptom severity and higher 
perceived functional status.   
 
 
 
Provocation Tests: 
§ Phalen’s: 
 
§ Tinel’s 
 
§ Carpal Compression Test: 
 
 
Sensation Tests: 
§ Sharp/dull: 
 
§ Pressure sensation: 
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Strength Tests: 
§ Grip: 
 
 
§ Pinch 
o Tip to tip: 
 
o Key: 
 
o 3 jaw chuck: 
 
§ Thumb abduction: 
 
 
Other tests: 
§ Flick sign: 
 
§ Thenar atrophy: 
 
§ Square wrist sign: 
 
§ Upper Limb Tension Test 1 (test for mobility and irritability of the 
median nerve): 
 
 
 
If you have any questions or concerns, do not hesitate to contact me at  
Ph: 343-9984 or email: bathb@shaw.ca. 
 
 
Sincerely,  
 
 
 
Brenna Bath BSc. PT, FCAMT, MSc (candidate) 
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APPENDIX I – CONSENT FORM 
 
You are invited to participate in a study entitled:  Reliability and Diagnostic Accuracy 
of Clinical Examination  and Self-Report Measures in Carpal Tunnel Syndrome.  
Please read this form carefully, and feel free to ask questions you might have. 
 
§ Name of researchers: 
Leonard Tan, Ph. D.  Brenna Bath, BSc PT 
(Professor, Supervisor) (Physical Therapist) 
Dept. of Community Health and Epidemiology MSc. Candidate CH&EP 
University of Saskatchewan   University of Saskatchewan 
       Phone:        Phone:  (306) 343-9984 
       Email:  bathb@shaw.ca 
 
§ The purpose of the study: To assess the reliability and validity of individual clinical 
examination items and self-report items for the diagnosis of carpal tunnel syndrome. 
 
§ Potential Risks: Some mild physical discomfort may be felt by the participants with 
some the physical tests; however, this risk will be minimized by physical screening 
done prior to the testing by a registered Physical Therapist. If a participant is found to 
have any pre-existing physical problems that would limit their safe participation in 
the study, they would not be allowed in the study.  
 
§ Possible benefits of the study to the participant and others:  Nerve conduction 
tests (i.e. electrodiagnostic studies) are thought to be the best way to diagnose carpal 
tunnel syndrome.  They can, however be time consuming, expensive to perform and 
uncomfortable patients. Clinical tests and questionnaires that accurately predictth 
epresence of carpal tunnel syndrome have the advantage of being relatively quick and 
easy to perform and could assist with earlier confirmation of a diagnosis.  Earlier 
diagnosis could lead to earlier and likely better treatment in some cases. The results 
of the additional clinical and self-report tests performed for this study can be shared 
(with your consent) with your referring physician so that they may have more 
information at their disposal to help you with your condition. 
 
§ The study procedures:  Study participants will be recruited from patients referred to 
Saskatoon City Hospital for electrodiagnostic testing due to arm, wrist or hand 
problems. As a participant, you will be asked to complete paperwork including 
information regarding your general health, age, education, income, work and hobbies.  
You will also be asked to complete questionnaires about your symptoms and 
functional abilities.  The paperwork will take approximately 15-30 minutes to 
complete. You will then undergo a series of clinical tests performed by a registered 
Physical Therapist.  The tests include carpal tunnel specific tests, strength and 
sensation measures and a test for the length of the median nerve (nerve in the arm).  
You may undergo the same series of clinical tests performed by a second registered 
Physical Therapist (this will be done with a random group from the study).  The 
clinical tests will take approximately 15-30 minutes to complete. The results of your 
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electrodiagnostic testing will be used to compare to the results of the papaerwork and 
additional clinical testing.  You will receive $10 to reimburse you for your time and 
parking.  This parking honorarium will also be paid to participants who choose to 
withdraw upon attending their study appointment. 
 
§ Confidentiality:  Confidentiality of study participants will be kept by assigning 
subject numbers to each subject.  Only the subject’s number will be present on 
paperwork.  The key linking participant name and subject number will be kept in a 
secure location onsite at the Physical Medicine and Rehabilitation   Department at 
Saskatoon City Hospital and will be destroyed upon completion of the data collection 
period.  Although the data from this study may be published and presented at 
conferences, the data will be reported in group form, so that it will not be possible to 
identify individuals. The consent forms will be stored separately from the results of 
the testing so that it will not be possible to associate a name with any given set of 
responses.   
 
§ Right to Withdraw: You are free to withdraw from the study at any time.  Withdraw 
from the study will not affect your academic or employment status, and/or access to, 
or continuation of, services provided by public agencies such as the University, 
hospitals, or social services.  Your access to treatment will not be affected by your 
decision to participate.  If you decide to withdraw, you may choose to have their data 
deleted from the study and destroyed.   
 
§ Researcher decisions and interpretations: If for any reason the researcher decides 
that involvement by a participant is not needed or not appropriate, the researcher can 
choose to discontinue the participant’s involvement in the study, in which case the 
participant’s data will be deleted from the study and destroyed. 
 
§ Reports and presentations: The information obtained from this study will be used in 
a number of different forms.  The information will be used in a master’s thesis and 
may be used in articles published in medical journals and in oral or poster 
presentations to groups of researchers and students. 
 
§ Questions:  If you have any questions concerning the study, please feel free to ask at 
any point; you are also free to contact the researchers at the numbers provided above 
if you have questions at a later time.  This study has been approved on ethical 
grounds by the University of Saskatchewan Behavioural Sciences Research Ethics 
Board on August 19th, 2004.  Any questions regarding your rights as a participant 
may be addressed to that committee through the Office of Research Services (966-
2084).  Out of town participants may call collect.    
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Consent to Participate:     
 
I, ______________________________________ (name), hereby acknowledge that: 
§ I have read and understood the description provided above. 
§ I have been provided with an opportunity to ask questions and my 
questions have been answered satisfactorily. 
§ I consent to participate in the study described above, understanding that I 
may withdraw this consent at any time. 
§ I agree that the researchers may access the results of my electrodisgnostic 
testing. 
§ I have received a copy of the consent form for my own records and, 
§ I would / would not (please circle one) like a summary of the additional 
test results sent to my referring physician. 
 
______________________ __________________ 
Participant    Date 
 
______________________ __________________ 
Researcher    Date 
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APPENDIX J- PARTICIPANT GENERAL PAPERWORK 
 
Thank you for your agreement to participate in this study.  Please answer the 
following questions to the best of your knowledge.  To ensure confidentiality, 
please do not put your name on any of the following pages.  If you have any 
questions about the questionnaires, please ask to speak to the study co-
ordinator. 
 
 
About You: 
 
1. Age:   _______ 
 
2. Gender: 
   Male   
   Female 
 
3. Current Marital Status (please circle):     
         Married 
           Separated  
 Divorced  
 Widowed  
 Never Married 
       
4. Education: 
         Did not complete Grade 12 
         High School 
         Trade School 
         Some University 
         University Degree 
 Graduate Degree 
       
5. Family Income: 
         <$15,000 
        $16,000-29,000 
 $30,000-59,000 
 $60,000-99,000 
 Equal to or greater than $100,000 
 
6. Height:  _______ 
 
7. Weight:  _______ 
 
8. Whish side is your dominant hand? 
 Right     Left    Both 
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About Your Job: 
 
9.  Please check your main form of work 
         paid work-full time 
         paid work-part time 
 unemployed 
 housework 
 disabled 
 student 
 retired 
 
10. If employed, what is your occupation: _____________ 
 
11.  If employed, does your job involve any of the following? 
         repetitive hand or wrist movements 
 work in cold environments 
 vibration through hands and wrists 
 
12.  Are you currently receiving benefits through the Worker’s Compensation        
Board (WCB) for your hand/wrist/arm problem?             Yes          No 
 
13 Are you currently receiving benefits through Saskatchewan Government 
Insurance (SGI) for your hand/wrist/arm problem?   Yes          No 
 
  
About your medical status: 
 
14.  Please check any of the following medical conditions that you may have or 
have had: 
          Diabetes 
 Rheumatoid Arthritis 
 Osteoarthritis 
 Fractured wrist 
 Thyroid condition 
 Other: _______________________________________________ 
 
15.  Do you smoke?           Yes                No 
 
About your symptoms: 
 
16. Which side do you have symptoms with your hand/wrist/arm? 
                Right         Left          Both 
 
 * If both sides bother you, which side is worse? 
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    Right          Left 
17.  How long have you had symptoms at your hand/wrist/arm? ___________ 
 
 
 
 
 
18.  HAND/ARM DIAGRAM:  Please shade in where you feel pain, 
numbness, tingling or burning sensations in your hands/arms. 
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APPENDIX K 
Physical Exam Reporting Form: CTS Study 
Date: _____________    Subject Number: _____________ 
Examiner Initials: ______________   
 
Provocation Tests:  
1. Phalen’s:   Right:  ____  positive  ____negative   
                                Left:  ____  positive  ____negative 
 
2. Tinnel’s:   Right:  ____  positive  ____negative   
     Left:  ____  positive  ____negative 
 
3. Carpal Compression:  Right:  ____  positive  ____negative   
                                                 Left:    ____  positive  ____negative 
Sensation Tests: 
1. Sharp/Dull:  Right:  ____  positive  ____negative  
 Left:  ____  positive  ____negative 
 
2. Pressure: Right:  ____  positive  ____negative   
Left:  ____  positive  ____negative 
 
Strength Tests: 
1. Grip (kg):  Right: trial 1:_________ trial 2:_________ trial 3:_______ 
     Left:   trial 1:_________ trial 2:_________ trial 3:_______ 
 
2. Pinch (kg): 
a. Tip to tip:  Right:  trial 1:_________ trial 2:_________ trial 3:_______ 
     Left:    trial 1:_________ trial 2:_________ trial 3:_______ 
 
b. Key:  Right: trial 1:_________ trial 2:_________ trial 3:_______ 
          Left:   trial 1:_________ trial 2:_________ trial 3:_______ 
 
c. 3 jaw chuck:  Right:  trial 1:_________ trial 2:_________ trial 3:_______ 
            Left:     trial 1:_________ trial 2:_________ trial 3:_______ 
 
3. Thumb abduction:     Right:  Grade (1-5) _______   Left: Grade (1-5) _______ 
 
Other Tests: 
1. Flick sign:  Right:    ____positive ____negative    Left:  ____positive ____negative     
 
2. Thenar atrophy: Right:    ____positive ____negative    Left:  ____positive ____negative     
 
3. Square wrist (mm): Right: A/P:_______  M/L :______ Left: A/P:_______M/L :_______ 
 
4. ULNTT 1:  
Right:  elbow ext ROM_________   Left: elbow ext ROM__________ 
____ pt’s symptoms reproduced   ____ pt’s symptoms reproduced 
____>10deg difference elbow extension  ____>10deg difference elbow extension 
____contralateral neck SF increased   ____contralateral neck SF increased  
or ipsilateral neck SF decreased symptoms           or ipsilateral neck SF decreased symptoms 
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APPENDIX L – CTS DIAGNOSTIC CRITERIA AND EDX PROCEDURES 
 
 
CTS Diagnostic Criteria for EDX: 
 
§ Positive EDX for CTS includes any one of the following: 
o Transpalmar difference between ulnar and median nerves of greater than 
0.3 ms peak latency on mixed nerve study 
o Antidromic sensory conduction velocity of less than 50m/s +/- amplitude 
less than 10 uV or absent sensory nerve action potential 
o Motor distal latency of >4.2 ms +/- amplitude of less than 5 mV. 
 
Electrodiagnostic Procedures: 
 
§ All EDX testing will be performed by a physiatrist. 
§ Bilateral median and ulnar motor and sensory nerve conduction testing will 
primarily be used in the assessment of suspected CTS. 
§ Electromyography (EMG) will typically not be used for the assessment of CTS 
and ulnar neuropathy unless severe neuropathy is suspected. 
§ EMG will likely be used for the assessment of radiculopathy, brachial plexopathy 
and other upper extremity neuropathies (i.e. radial neuropathy). 
§ EMG assessment involves needle insertion into key muscles and evaluation of 
insertional and spontaneous activity as well as motor unit recruitment. 
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APPENDIX M 
CTS STUDY:  EDX RESULTS 
 
EDX results 
§ Positive EDX for CTS includes any one of the following: 
o Transpalmar difference between ulnar and median nerves of greater than 0.3 ms 
peak latency 
o Antidromic sensory conduction velocity of less than 50m/s +/- amplitude less than 
10 uV 
o Motor distal latency of >4.2 ms +/- amplitude of less than 5 
 
 
Right:      Positive  Negative  
  
  Mild   Moderate  Severe 
 
 
Left:   Positive  Negative 
 
  Mild    Moderate  Severe 
 
 
Differential Diagnosis (circle any / all that apply) 
 
CTS 
 
 
Ulnar Neuropathy 
 
 
Radial Neuropathy 
 
 
Brachial Plexopathy 
 
 
Cervical Radiculopathy 
 
 
Diabetic Neuropathy 
 
 
Other: _________________________________________________ 
 
 
Unknown 
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APPENDIX N 
SPSS Logistic Regression Results Tables 
 
General Classification Group: 
 
 
 
Variables in the Equation 
 
  B S.E. Wald df Sig. Exp(B) 
              
Step 
1(a) 
sss6cat(1) 22.812 17974.852 .000 1 .999 8077377339.791 
  Constant -21.203 17974.852 .000 1 .999 .000 
Step 
2(b) 
ulttsymp1(1) 1.856 1.102 2.836 1 .092 6.400 
  sss6cat(1) 23.968 17571.092 .000 1 .999 25664273
747.971 
  Constant 
-22.829 17571.092 .000 1 .999 .000 
a  Variable(s) entered on step 1: sss6cat. 
b  Variable(s) entered on step 2: ulttsymp1. 
 
 
 
Restricted Classification Group: 
 
 
 
 Variables in the Equation 
 
  B S.E. Wald df Sig. Exp(B) 
sss6cat(1) 2.485 1.118 4.940 1 .026 12.000 Step 
1(a) Constant -1.792 1.080 2.752 1 .097 .167 
sss6cat(1) 2.091 1.152 3.295 1 .069 8.095 
ctqsslev(1) 1.170 .619 3.569 1 .059 3.222 
Step 
2(b) 
Constant 
-2.230 1.141 3.820 1 .051 .108 
a  Variable(s) entered on step 1: sss6cat. 
b  Variable(s) entered on step 2: ctqsslev. 
 
 
 
 
 
 
